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Abstract 
Pregnancy is characterized by slight insulin resistance (IR), impaired glucose clearance and 
compensatory increased insulin secretion. More severe IR may, however, result in pancreatic β cell 
failure during pregnancy, and in turn leads to prolonged insulin insensitivity after birth, and/or an 
increased risk of diabetes in later life. This condition is known as gestational diabetes mellitus 
(GDM) in pregnant women those, in particular, who suffer from obesity. Although IR has been 
considered as a factor to increase the risk of laminitis and osteochondritis dissecans (OCD) in 
horses, there is no reported direct evidence showing that GDM occurs in pregnant mares. Hence, the 
present research aimed to study the occurrence of IR in pregnant mares with different body 
condition score (BCS) and potential long-term effects in the subsequent pregnancy.  
 
Experiment 1: In the first year, 13 pregnant mares were allocated into either a high body condition 
group (HBCS, n=6) or low body condition group (LBCS, n=7) based on BCS assessed at mid 
gestation on a scale of 1 to 9. The two groups were fed separately with either a high energy diet 
(150 % DE requirements) or a moderate energy diet (100 % DE requirements) to attain a BCS of 
HBCS ≥ 6 and LBCS ≤ 4, respectively, during the last trimester of pregnancy. Weekly blood 
samples were taken from week 41 to 46 of pregnancy to confirm the differences between the groups 
by determining the basal leptin concentrations. Frequently sampled intravenous glucose tolerance 
tests (FSIGTT) were performed at day 290 and 320 of gestation while insulin and glucose responses 
were analyzed by minimal model analyses to determine insulin sensitivity (Si), glucose 
effectiveness (Sg), acute insulin response to glucose (AIRg) and disposition index (DI).  
 
Experiment 2: In the subsequent year, lactating mares from the previous experiment were mated 
again prior to examinations for ongoing dysfunction of pancreatic β cell. Four mares from each of 
the previous HBCS and LBCS groups were selected for the study. During pregnancy animals were 
individually fed to ensure similarity in BCS between the groups and BCS were evaluated frequently. 
An oral glucose tolerance test (OGTT) was carried out at day 325 of gestation to study the insulin 
and glucose responses in late pregnancy.  
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It was found in Experiment 1 that the BCS in the HBCS group was significantly (P<0.001) higher 
than those in the LBCS group at day 290 (6.3±0.4 vs. 4.1±0.3) and day 320 (7.2±0.5 vs. 3.3±0.3) of 
gestation. It was noted that BCS in the HBCS group was significantly (P<0.05) increased, whilst 
those in LBCS group significantly (P<0.01) decreased over the period. Live weight was, however, 
similar (p>0.05) between the groups during the period. In addition, Plasma leptin was significantly 
higher (P<0.05) in the HBCS group as compared to those in the LBCS group from week 41 to 46 of 
gestation. There was no significant difference found (p>0.05) in basal insulin or glucose levels 
between the groups at either day 290 or day 320 of gestation. No significant change (p>0.05) was 
seen in the minimal model parameters of the HBCS group in late gestation. The Si and DI of the 
LBCS mares were, however, significantly (P<0.01) lower than those of the HBCS mares on both 
day 290 (Si 0.94±0.11 vs. 0.22±0.14; DI 226.7±57.1 vs. 33.9±28.8) and day 320 (Si 1.07±0.35 vs. 
0.10±0.06; DI 282.9±79.1 vs. 4.3±2.7). Mean Si values of the LBCS mares were lower than 0.1 in 
majority of the cases at day 320 of gestation, which can be determined as severe IR. AIRg levels 
were similar (p>0.05) between the groups at day 290, but were significantly (P<0.01) lower in the 
LBCS mares than in the HBCS mares at day 320 (347.5±60.8 vs. 80.3±24.1). In contrast, The Sg 
was not distinct (p>0.05) between the groups at either time.  
 
In experiment 2, no significant difference in BCS was found between the previous high body 
condition (PHBCS) and previous low body condition (PLBCS) mare groups (4.3±0.3 vs. 4.3±0.3, 
respectively) as expected, while a significant increase in live weight (10%) was found in the PLBCS 
mares (P<0.05). Prior to OGTT at days 325 of gestation, levels of basal insulin (1.8±0.5 vs. 
2.3±1.3), glucose (54.9±9.4 vs. 72.0±10.5), leptin (1.8±0.1 vs. 2.3±0.52) and adiponectin (12.5±1.6 
vs. 9.9±1.1) were not significantly different (p>0.05) between the mare groups. In terms of the 
OGTT response, the total area under curves (AUC) of both insulin and glucose were not 
significantly different (p>0.05) between the mare groups. However, glucose concentration 
decreased significantly (p<0.05) in 90 min after loading glucose in PHBCS mares, whilst it 
increased continuously (p<0.05) in PLBCS mares until achieving a peak value at 150 min. Plasma 
insulin rapidly increased (p<0.05) in response to glucose load in the PHBCS group. In contrast, 
defective insulin secretion was observed in the PLBCS group with peak values at 210 min. 
Additionally, a significantly (P<0.05) lower AUC of insulin was found in the PLBCS group during 
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the first 60 min as compared to the PHBCS group indicating the β cell failure in the PLBCS mares. 
 
Compelling evidence has been obtained that a mare‟s physical status (ie body condition) can alter 
her metabolism during pregnancy. Pregnant mares with low body condition are at risk of developing 
GDM during late pregnancy. Therefore, it is important to maintain appropriate nutrient intake and 
body condition when managing mares during late pregnancy.  
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Introduction and Objectives of the Study 
1.1 Introduction………………………………………………………………………………...…….1 
1.2 Economic contribution of the horse industry…………………………………………………….1 
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1.1 Introduction 
Horses have roamed the earth for millions of years having evolved from a small dog like creature to 
the horse of today (Budiansky, 1997). To utilize the herbage and forages, high in fibre or cellulose, 
on which it evolved, the horse has developed an enlargement of the hindgut or large intestine as a 
fermentation chamber, for micro-organisms. The formation of a symbiotic relationship with bacteria 
has allowed the horse to live satisfactorily on low quality pastures (Janis, 1976). Today the horse is 
an important part of society and is often fed diets that are very different to those on which it evolved. 
This may have consequences for equine health and welfare.  
1.2 Economic contribution of the horse industry  
The place of horses in society has changed over time. In Australia horse numbers peaked about the 
time of the First World War and the gradually declined as they were replaced by the combustion 
engine. Horse numbers stated to increase again after the Second World War as pleasure horse riding 
increased (Gordon, 1991).  
 
The equine industry contributes approximately $ 6 billion annually to the Australian economy 
which is almost 90% of the livestock industry contribution. (Gordon, 2001). In Australia, 
expenditure on the breeding segment is around 15 % ($880 million) of the total (Gordon, 2001). In 
the 2012 to 2013 Thoroughbred season, 21,000 mares were covered and 13,000 foals survived 
giving a live foal ratio of 65.1% (Foreman, 2013). This low foal percentage indicates significant 
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breeding wastage. Moreover, there is much industry concern about subsequent wastage from foals 
with developmental orthopaedic disease (DOD) that includes osteochondrosis (OC), subchondral 
bone systs (SBC) and angular limb deformities. Aldred (1998) estimated that up to 10% of foals 
with DOD could not be sold and this cost to the Thoroughbred industry (Hunter Valley, the major 
area for Thoroughbred breeding in Australia) is about $ 9.8 million annually. There is increasing 
evidence that maternal nutrition during gestation and lactation can affect endocrine responses of the 
offspring and alter neonatal health (Yajnik and Deshmukh, 2008). Therefore, studies or research 
regarding the nutritional status of mares during pregnancy needs to be undertaken.  
1.3 Background to this study 
To conduct nutrient studies in mares would be require many animals and would be very expensive. 
An alternate approach is to do research with mares of differing in BCS as body condition reflects 
energy status of the animal. In previous studies conducted in this laboratory, Dobbs et al (2011) 
demonstrated that maternal diet during late gestation and lactation can influence Si and glucose 
dynamics in the foal during early post-natal life. This occurred with only small differences in body 
condition of the mares. Therefore, in this follow-up study, mares with much greater difference in body 
condition were examined.  
1.3.1 Insulin resistance  
It has been reported that hyperinsulinaema may occur in up to 10% of horses and 28% of ponies and 
this frequency may be increasing (Geor et al., 2007, McGowan et al., 2008). Using the figures 
quoted above from Foreman (2013), there might be approximately 2100 pregnant Thoroughbred 
mares affected annually with hyperinsulinaema in Australia. Hyperinsulinaema is due to impaired 
tissue sensitivity to insulin, resulting in greater production and secretion by the pancreas of the 
hormone. This will develop into type 2 diabetes in humans and IR in horses (Geor, 2008). Although 
the mechanisms of IR are not completely understood, the association between IR and laminitis is 
recognized (Treiber et al., 2005c). Moreover, in horses and ponies with laminitis, obesity is 
suspected as a major causative factor as it induces a chronic inflammatory response (Carter et al., 
2008). Johnson (2002) suggested using the term equine metabolic syndrome (EMS) to describe 
horses with laminitis-predisposed phenotypes such as obesity, IR, hyperinsulinaemia, 
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hyperleptinaemia and current or historical laminitis (Treiber et al., 2006b).  
1.3.2 Insulin resistance during pregnancy 
Pregnancy is characterized by mild insulin insensitivity due to the increased foetal requirement for 
glucose (Bell et al., 1999). In late 1970‟s, GDM was defined in humans and classified as any degree 
of impaired glucose tolerance which occurs during pregnancy (Group, 1979). The prevalence of 
GDM in women is approximately 4 to 12% and depends on race. Most women return to normal 
after labour (Group, 1979). However, it has been shown that historical IR can enhance the 
development of GDM and predispose women to the development of diabetes in later life 
(O'Sullivan, 1991). Moreover, there is link between GDM and body mass index as a higher 
incidence of GDM occurs in obese compared to normal women (Ehrenberg et al., 2002).  
1.4 Objectives  
In a previous study, mares that were fed a high energy diet during the last trimester of pregnancy 
had significantly higher basal glucose and insulin concentrations than mares fed less well (Dobbs 
2013). However, no significant difference in any minimal model parameter was observed with a 
FSIGTT.  In that study, mares only had small differences in live weight and body condition. 
Therefore, in this follow-up study, insulin and glucose responses were examined in pregnant mares 
with disparate body condition. The hypothesis explored was that obesity would exacerbate IR in 
pregnant mares. This was examined in the first experiment with the specific objective of 
determining whether IR differs between pregnant mares with different BCS. 
In this study the insulin dynamics and glucose metabolism in mares with a low BCS were 
reminiscent of women with GDM, especially β cell failure. To date, there are no reports of GDM 
per se in mares.  This novel result was further explored in a second experiment with the specific 
objective of determining if abnormal insulin and glucose responses occur in subsequent 
pregnancies.  
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2.1 Scope of the review 
In this chapter, factors involved in these two experiments are reviewed and evidence and resources 
for discussion are provided. Insulin resistance, a change at both the tissue and cellular level causing 
resistance to the insulin mediated glucose disposal, has been reported as the main factor of a cluster 
of metabolic disturbances in humans including hypertension, hyperinsulineamia, 
non-insulin-dependent diabetes mellitus (NDDM) and cardiovascular disease (Brands and Hall, 
1992, Kahn, 2003, Reaven, 2004). This raises a point of interest that IR may be the aetiology of a 
number of metabolic abnormalities in horses such as laminitis, poor reproductive function and 
developmental orthopardic disease (DOD) (Pagan et al., 2001, Hoffman et al., 2003a, Treiber et al., 
2006a). Therefore, the concept of insulin actions and glucose metabolism will be initially presented 
for illustrating knowledge of the mechanism of IR and its effect.  
In addition, obesity has been considered as a major factor in causing long term metabolic disease 
which is associated with blood glucose dysregulation, herpyinsulinaemia and IR (Klimes, 2002).  
In recent studies, it has been found that obesity and diabetes are linked to the effects of 
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inflammation (Shoelson et al., 2006). In horses, modified diet is suspected as the main cause of 
obesity due to specific dietary factors such as high non-structural carbohydrates that influence an 
increase of insulin and glucose concentrations linking to hyperinsulinaemia and dysfunction of β 
cell (Hoffman et al., 2003b). According to this, body condition evaluations and diet are considered 
in this review to investigate influences on insulin and glucose metabolism.  
2.2 Physiology of glucose and insulin 
2.2.1 Glucose metabolism 
Glucose is the main source of energy for mammalian cells. It originates from digestive absorption, 
gluconeogenesis (generation of glucose from non-carbohydrate sources) and glycogenolysis 
(breakdown of glycogen when an organism is suffering hunger). Beardall et al. (2006) concluded 
that 50% of the blood glucose is oxidized within muscle cells, 35% is accumulated as glycogen and 
15% is released as lactate and alanine. Blood glucose normally increases after food intake then 
decreases to a relatively stable level. Once the blood glucose concentration increases, it is removed 
by several organs, tissues and cells including the brain, skeletal muscle, liver and adipose tissues by 
glucose transporters (GLUT) on cell membranes. A high concentration of blood glucose is 
considered to be toxic (Yeo and Sawdon, 2013, Haller, 1998). There are several glucose transporters 
(GLUT) located on different cell surfaces involved in this process. GLUT 1 and GLUT 5 are the 
non-insulin stimulated transporters, while, in contrast, GLUT 4 is an insulin dependent transporter. 
Glucose promotes its own uptake by peripheral tissues and suppresses hepatic production, 
independent of an increase in insulin action called “glucose effectiveness” (Sg) (Bergman et al., 
1985). The maintenance of glucose homeostasis is regulated by hormonal influenced by brain and 
active on adipose tissues, kindney, liver and muscle tissues, which is illustrated in Figure 2.1. In the 
presence of high blood glucose levels, insulin secretion increases and insulin sensitive tissues are 
activated by serum insulin, via insulin receptors, to uptake glucose. This is of lesser influence when 
glucose levels return to normal (Katz et al., 1983). Factors such as carbohydrates and fat levels in 
the diet and the concentrations of free fatty acids in blood influence the concentration of blood 
glucose (Yeo and Sawdon, 2013).  
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Figure 2.1: Hormonal regulation of blood glucose (Yeo and Sawdon, 2013). 
 
2.2.2 Physiology of insulin 
Insulin is a major peptide hormone secreted by the pancreatic β cells located in islets within the islet 
of Langerhans. Its primary function is to participate in whole-body glucose homeostasis for the 
survival of animals although lipogenesis, diminishing lipolysis, DNA synthesis and cell replication 
also are influenced by insulin. Its primary role is to reduce hepatic glucose output by decreasing 
gluconeogenesis and glycongenolysis and enhancing glucose uptake into muscles and adipose 
tissues (Pessin and Saltiel, 2000). This anabolic reaction releases energy by breaking large 
molecules into complex molecules. Once insulin concentrations rise, glucose is removed from the 
blood stream into insulin sensitive tissues, including the liver, adipose tissue and skeletal muscle 
which is the main site of insulin-stimulated glucose disposal.  
Insulin is pre-synthesized in the endoplasmic reticulum which contains an A-chain, a B-chain and a 
connecting C-peptide (Wilcox, 2005). It is then transferred to Golgi apparatus where the pro-insulin 
is elevated the c-peptide prior to releases of insulin (Hutton, 1994). Although there are some 
differences in the amino acid composition of insulin in different species, the biological activities of 
insulin are not highly species-specific (Cunningham, 2002).  
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With regard to insulin secretion, glucose is the primary secretagougue that enters the β cells with the 
aid of the glucose transporter-2 (GLUT-2) (Trout et al., 2007). Glucose is then phosphorylated by 
glucokinase leading to the generation of adenosine triphosphate (ATP). This increase of ATP alters 
the ratio of ATP and adenosine diphosphate (ADP) to block the ATP-sensitive potassium (K
+
) 
channel. Subsequently, decreased K
+
 activates the voltage-dependent calcium (Ca
+
) channels, 
resulting in an influx of  Ca
+
 into the β cells enhancing the secretion of insulin from insulin 
containing granules (Schmidt and Hickey, 2009) (Figure 2.2).  
 
Figure 2.2: Glucose stimulus for insulin release from the pancreatic β cell (Molina, 2013).  
 
2.2.3 Action of insulin 
Briefly, the actions of insulin mainly target the anabolism and the promotion of the synthesis of 
carbohydrates, fats and proteins as shown in Table 2.1. Insulin achieves its function by binding to 
the insulin receptor on insulin sensitive tissues where the insulin signaling pathway is activated and 
where glucose uptake occurs in a healthy situation. Normally, this process occurs in skeletal muscle 
(the main depot), adipose tissue and the liver. However, there are factors affecting insulin 
sensitivities such as pregnancy, obesity and pressure. The insulin mediated glucose transport 
induced by an effective insulin stimulus is defined as “insulin responsiveness” (Kahn, 1978). 
Increased insulin responsiveness triggers glucose uptake and a proportional upward skewing in the 
insulin dose-response curve (Kahn, 1978). A half way response induced by insulin concentration 
was defined as “insulin sensitivity” by Geor and Harris (2009).  
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It is known that the insulin receptor, a tetrameric glycoprotein, contains two extracellular α-subunits 
and two plasma membrane-spanning β-subunits which include insulin-like growth factor-1 (IGF-1) 
receptor (Saltiel and Kahn, 2001). Normally, when α-subunits receive insulin from plasma there is 
an inhibition of tyrosine kinase activities of the β-subunits. This promotes the autophsophorylation 
on β-subunits inducing further kinase activity of insulin receptor substrate 1 (IRS-1) or IRS-2 (Patti 
and Kahn, 1998). Subsequently, the phosphoinositide 3-kinase (PI(3)K) is summoned to the cell 
membrane and catalyzes the transformation of phosphoinositol diphosphate (PIP2) to 
phosphoinositol triphosphate (PIP3) (Choi and Kim, 2010). Corvera (2001) demonstrated that 
PI(3)K has two main functions: to alter the intake of glucose; and protein synthesis. One of these is 
via the AKT pathway where Protein Kinase B (PKB) is activated by the energy passed from PIP3 
via factor PDPK-1 to enhance the insertion and movement of the glucose transporter 4 (Glut-4)  
into the cell membrane to deliver glucose into the cell (Sakamoto and Holman, 2008) (Figure 2.3). 
Impaired phosphorylation of the insulin receptor in response to insulin has been observed in the 
skeletal muscle of morbidly obese individuals with type 2 diabetes (Goodyear et al., 1995). One 
concept presented by Kronfeld et al (2005) is that insulin receptor dysfunction may contribute to 
both insulin insensitivity and insulin ineffectiveness resulting in a decreased glucose transportation 
and an alteration of glucose metabolism inside the cell. 
 
 
Figure 2.3: Traffic of the normal insulin signalling pathway (Banse, 2013). 
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Table 2.1: Insulin effects on carbohydrate, fat and protein metabolism (Molina, 2013). 
Metabolic 
effects 
Insulin stimulates Insulin inhibits 
Carbohydrate 
metabolism 
 Glucose transport in 
adipose tissue and muscle 
 Rate of glycolysis in 
muscle and adipose tissue 
 Glycogen synthesis in 
adipose tissue, muscle, and 
liver 
 Glycogen breakdown in muscle and liver 
 Rate of glycogenolysis and gluconeogenesis in the 
liver 
Lipid 
metabolism 
 Fatty acid and 
triacylglycerol synthesis in 
tissues 
 Uptake of triglycerides 
from the blood into adipose 
tissue and muscle 
 Rate of cholesterol 
synthesis in the liver 
 Lipolysis in adipose tissue, lowering the plasma 
fatty acid level 
 Fatty acid oxidation in muscle and liver 
 Ketogenesis 
Protein 
metabolism 
 Amino acid transport into 
tissues 
 Protein synthesis in 
muscle, adipose tissue, 
liver, and other tissues 
 Protein degradation in muscle 
 Urea formation 
 
2.3 Insulin resistance 
2.3.1 Concept of insulin resistance  
Insulin related metabolic diseases in humans are usually associated with two major areas, impaired 
Si and lack of insulin production from β cell defined as type 2 diabetes and type 1 diabetes. The 
reduction of tissue sensitivity to circulating insulin has been detected and defined as IR. When 
insulin insensitivity occurs, the organ‟s purpose to clean glucose from the blood stream is hindered 
by an insensitive response from target tissues. Therefore, the insulin-dependent glucose uptake by 
the liver, muscles and adipose tissues is decreased, and specifically, the pancreas compensates by 
secreting increased amounts of insulin to maintain euglycemia. However, this reaction is only 
temporarily efficient. A prolonged combination between hyper-secretion of insulin and increased IR 
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eventually develops into an impaired glucose tolerance and an exhaustion of pancreatic β cell 
resulting in delayed clearance of glucose and reduced insulin secretion, featured as clinical type 2 
diabetes. This differs from a reduction in insulin action due to the reduced circulating insulin as 
occurs in type 1 diabetes (Treiber et al., 2006a). The glucose intolerance may be detected by either 
an intravenous glucose tolerance test or oral glucose tolerance test where a delayed clearance of 
glucose is observed (Johnson, 2002). Johnson (2002) indicated that IR may precede the 
development of impaired glucose tolerance where the pancreas is still able to secrete compensatory 
insulin.  However, if this state is exacerbated causing β cell failure, the pancreas may not be able to 
respond to blood glucose increases resulting in type 2 diabetes.  
 
Insulin resistance may be enhanced by body status to cause various diseases. The main suspect 
referred to is obesity or specifically fat mass. Several factors have been reported to be responsible to 
IR in obesity (Després and Marette, 1999). This will be discussed separately in the next section. 
Apart from obesity, pregnancy is characterized by slight IR. Bell (1999) indicated that Si decreases 
in late pregnancy in order to increase blood glucose to support foetal development in humans. In 
GDM where there is a higher blood glucose concentration during gestation due to the insulin 
insensitivity resulting in women having a higher risk of having super babies and dymatural babies 
with respiratory distress syndrome (Jones, 2001). Currently, in studies regarding equine insulin, it 
has been shown that IR affects athletic horses and causes a poor performance, metabolic syndrome 
at mid-aged and a lowered fertilization rate in mares with obesity (Frank et al., 2010, Johnson et al., 
2009).  
 
In horses, a lack of GLUT-4 insertion within the membrane of the skeletal muscles has been 
reported to be the main reason for IR (Waller et al., 2011). Moreover, results obtained by Waller et 
al. (year?) indicated the total value of the GLUT-4 was similar between IR horses and normal 
horses. The report also mentioned that the possible defect may occur in Akt substrate of kilodalton 
160 (AS160). Further investigations, however, need to be carried out to obtain a better 
understanding (Waller et al., 2011). 
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Obesity has been considered to be a major hazard related to various diseases such as non-insulin 
dependent diabetes (type 2 diabetes), dyslipidaemias, hypertension and cardiovascular diseases 
(Kahn, 1996, Berg, 1993). The levels of obesity have increased steadily in developed countries 
where tremendous amounts of money have been spent on healthcare (Wolf and Colditz, 1996, 
Lissner et al., 2000, Kuczmarski, 1992). However, obesity is also defined as an “independent” 
potential risk in some situations due to the fact that some obese individuals may not present other 
obvious complications, but will go on to develop type 2 diabetes, hypertension and cardiovascular 
diseases (Björntorp, 1988, Kissebah et al., 1989). Although there is evidence from previous studies 
that there is a correlation between obesity and IR, the actual mechanism of this is still being 
investigated (Kissebah et al., 1989, Björntorp, 1988, Kissebah and Peiris, 1989, Després et al., 
1990). Recently, there has been growing evidence for the possibility that Si may be impaired by 
inflammation or hormones produced by adipose (Xu et al., 2003, Ahima and Flier, 2000). 
2.3.2 Insulin resistance in horses 
Insulin resistance has an increased risk of prevalence in horses. However, its effects, mechanisms 
and potential treatments are still under investigation. It has been noted that the impact of IR is 
increasing in horses resulting in an increase in various health problems (Geor, 2008). Evidence has 
been obtained from a general survey that up to 28% of horses may have hyperinsulinaemia 
although this may vary in different breeds (Geor et al., 2007).  
 
Insulin resistance refers to insensitivity at the cell surfaces and also to several disorders inside the 
insulin-sensitive cells, notably muscle, adipose tissues, and liver. This can be divided into three 
levels: before the cell receptor, at the cell receptor and distal to the cell receptor (Ronald, 1978). In 
horses, most of the disorder and disease is related to the circulating insulin failing to affect the 
sensitive tissues (skeletal muscles, adipose tissues and liver) which differs from the situation 
humans (Geor, 2008). Obesity may be the main factor that can be associated with most of the 
equine IR which may physiologically alter lipid metabolism to cause potential results such as 
glucose intolerance, endothelial dysfunction, haemodynamic pathology and assent expression of 
inflammatory markers (Reaven, 2004).  
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In equine health, IR and hyperinsulinaemia now are consequently deemed to increase the risk of 
laminitis and to affect the offspring (Treiber et al., 2006a). The hypothesis mat there is a link 
between IR and laminitis has arisen it was found, using a hyperinsulinaemic-euglycaemic clamp 
model that laminitis was induced in ponies with high concentrations of insulin intravenous infusion 
of high doses of insulin (Asplin et al., 2007). However, it is debatable that whether 
hyperinsulinaemia or changes of glucose metabolism are responsible to the induction of laminitis 
because both insulin and glucose are altered during insulin infusion. Technically, the actual 
mechanism of IR-associated laminitis is unclear, but the pasture-associated laminitis resulting from 
IR is considered by some researches to be the most prevalent form of the disease (Geor and Frank, 
2009). Moreover, IR related effects on breeding and offspring are also considerable and this will be 
discussed below.  
The „Equine metabolic syndrome‟ (EMS) is described as features of obesity, regional adiposity, 
hypertriglyceridaemia, hyperleptinaemia and hypertension shown in horses with IR (Frank, 2009, 
Treiber et al., 2006a, Bailey et al., 2008). Although IR is often associated with hyperglycaemia in 
humans, there is evidence showing comparable normoglycaemia and mild hyperglycaemia in IR 
horses (Treiber et al., 2005c). Moreover, it has been suggested that „Equine Cushing’s Disease‟ is 
associated with chronic IR (McFarlane, 2011). 
2.3.3 Insulin resistance in pregnant mares 
Glucose uptake and utilization in maternal tissue is controlled by blood insulin. However, foetal 
glucose uptake is dependent primarily on the glucose concentration gradient across the placenta 
(Evans, 1971). Evans (1971) indicated that the glucose entry rate of horses did not change during 
pregnancy but the higher glucose requirement of the foetus alters the redirection of glucose from 
maternal tissues. Due to the variability of glucose gradient between the blood and placenta in mares, 
glucose delivered to the foetus can be altered by increasing maternal glucose concentrations (Bell et 
al., 1999). Normally, in early pregnancy, the function of insulin in accelerating glucose clearance 
will be maintained at the same level. However, proceeding to late pregnancy, the response of insulin 
to glucose increases as a result of the integrated decreases of Si. In humans, Si increases at 12 to 14 
weeks of pregnancy and declines afterward resulting in IR for the rest of pregnancy (Kirwan et al., 
2002). Pancreatic insulin failure may occur in 2 to 4% of pregnant women resulting in a condition 
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called gestational diabetes. This may be due to defects of insulin-receptors-substrate-1 and 
impairment of beta-subunits on insulin receptors (Friedman et al., 1999).  
A similar GDM-like syndrome has been reported in mares at more than 270 days of gestation 
(Fowden et al., 1984b). It would appear that the large foetal demand for glucose is met by reducing 
maternal glucose utilization to a minimum in late gestation. In research conducted by Fowden‟s 
team, basal plasma insulin and glucose were not significantly different between mares at less than 
270 days of gestation and non-pregnant mares before feeding or 4 to 6 hours after feeding. However, 
following feeding, pregnant mares had higher insulin and glucose concentrations and a more rapid 
increase in insulin and glucose than non-pregnant mares. The difference was more significant as 
pregnancy progressed. In addition, β cell efficiency decreased in mares at less than 270 days of 
gestation comparing with an increase in β cell function in mares after 270 day of gestation. This 
may be due to the need for glucose to be oxidized or stored as glycogen to prepare for the last 
trimester of pregnancy. Reduced β cell function may be due to the need for the mare to increase the 
total glucose level to support foetal requirements in the last period of gestation. Treiber et al. (2006a) 
mentioned that this endocrine regulation is due to two processes: increased pancreatic insulin 
synthesis and pancreatic β cell function regulation in the placenta. Although peripheral Si can be a 
factor in slowing down the clearance of glucose into maternal tissues to support enough glucose for 
foetoplacertal tissues, low Si may be a risk to energy balance in mares (Clapp, 2002). Others 
studying on the insulin-glucose correlation in foetus have demonstrated that IR may change 
naturally in relation to age and species. Glucose administration has been reported to have no 
significant effect on foetus in early pregnancy, but the response by β cell to glucose dose increases 
with foetal age (Fowden et al. 2005). IR may develop for the first day after foaling (Holdstock et al., 
2004). Fowden et al. (2005) also found that premature foals have decreased insulin secretion in the 
immediate post natal period compared to full-term foals. Although it has been reported that, in 
Standardbreds, new-born foals are more insulin resistant than mature horses (Ralston, 1996), while 
other studies reported that the decreases in Si with increasing age were related to the environment, 
diet, genetics and other acquired factors (Barbieri et al., 2001). Dobbs et al. (2011) found that foals 
from mares with a higher BCS (3.9±0.04 vs 3.5±0.07) did not show significantly lower Si but 
showed higher levels of basal serum insulin and glucose as compared to foals from mares with a 
lower BCS. However, this requires further study with mares of more disparate BCSs.  
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Currently, there is no authorized medicine to treat IR in horses, but general methods are suggested 
by veterinarians such as weight control, increased exercise and dietary management to 
optimistically reduce the effects of IR. All such potential treatments focus on: reactivating the 
insulin receptors; stimulating glucose uptake by other pathways; reducing effects from adipose 
tissue; and reducing oxidative stress.  
2.3.4 Measurements of insulin resistance  
The optimized diagnosis of IR is based on the accuracy of insulin measurements. There is, however, 
no particular assay kit for equine insulin quantification. Although there are some differences in the 
amino acid composition of insulin in different species, the biological activities of insulin are not 
highly species-specific (Cunningham, 2002). Multiple assays may be advised to measure equine 
serum insulin concentrations for accuracy due to the different substitutions between human 
(molecular weight, 5808 Da) and equine insulin (molecular weight, 5748 Da) (Ho et al., 2008). In 
particular, amino acid 30, one of the substitutions of insulin, is threonine in humans and alanine in 
horses (Borer-Weir et al., 2012). The radioimmunoassay (RIA) is a competitive antigen binding 
method using radioactive (I
125
) insulin. Although RIA has been validated to be a common method 
for measurements for serum insulin concentrations in horses (Tinworth et al., 2009), several flaws 
are of concern such as underestimated insulin concentrations (Tinworth et al., 2011a) and a poor 
agreement at high insulin concentrations (Borer-Weir et al., 2012). Moreover, RIA may be 
considered as an inconvenient assay due to its overnight incubation and because of the use of 
radioactive isotopes. 
 
The determinations for insulin-glucose response require comprehensive knowledge of Si, enteral 
glucose absorption and insulin secretion. Kahn (1978) stated that IR can be divided into and occurs 
at three levels: before the cell receptor; at the cell receptor and distal to the cell receptor. Therefore, 
insulin degradation, subdued binding of insulin and its receptor, and impaired downstream 
signalling pathway are concerns in IR (Kronfeld et al., 2005).  
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To diagnose IR in humans， it is common to calculate fasting serum glucose and insulin 
concentrations. However, in the case of pregnancy, the fasting glucose challenge may be variable 
due to pregnancy naturally being accompanied by slight IR. It is challenging to measure the fasting 
value in an animal affected by stress, the environment or other factors. An OGTT is usually applied 
to pregnant women to detect a potential insulin disorder. However, incretin hormones may affect 
insulin secretion during archenteric absorption and glucose may be altered by non-insulin dependent 
glucose disposal. Therefore, although fasting measurements may detect insulin and glucose 
dysregulation, dynamic tests may be applied to adjust the error (Muniyappa et al., 2008). It is 
known that various dynamic tests for a more accurate assessment of Si are adapted for use in horses 
(Treiber et al., 2005b). Two methods will be focused on in this review.  
 
The FSIGTT is a reliable technique to detect Si in horses (Pratt et al., 2005). Data from FSIGTT can 
be interpreted by minimal model resulting in Si, Sg, AIRg and others. Advances in the simple 
intravenous glucose tolerance test (IVGTT) have been adapted for use with horses (Mehring and 
Tyznik, 1970). Briefly, the IVGTT includes measurements of fasting blood glucose concentrations 
then samples that are subsequently taken at 15, 30, 60, 90 min and every 60 min over the next 6 
hours for measurement of glucose and insulin (Firshman and Valberg, 2007). The FSIGTT was 
modified from IVGTT which requires a more intensive sampling and involves separated insulin 
kinetics (Pratt et al., 2005). In FSIGTT, a 0.3g/kg of glucose are injected after a basal sample is 
taken, followed by an administration of insulin (30 mIU/kg) at 20 min. Blood samples are taken at 1, 
2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 26, 27, 30, 35, 40, 50, 60, 70, 80, 90, 120, 150 
and 180 min for measurements of plasma glucose and insulin concentrations. According to the 
recent evidence, a Si below 1.0 is consistent with insulin resistance (Burns et al., 2010). 
 
17 
 
 
Figure 2.4 Diagram of the minimal model compartments used to interpret FSIGT (Hoffman et, al 
2003b).  
 
Glucose and insulin dynamics from FSIGT are appropriately interpreted by the minimal model, a 
mathematical construct that glucose disposal into glucose effectiveness, or the capacity of glucose 
to mediate its own disposal independent of plasma insulin, and insulin sensitivity, or the capacity of 
insulin to promote glucose disposal (Hoffman et al. 2003b). Previous study has used such minimal 
model in equine study (Hoffman et al 2003b). The outcomes of minimal model are Sg, the capacity 
of the cells to uptake glucose without insulin mediation, Si, the efficiency of insulin to accelerate 
glucose uptake by cells (Boston et al., 2003), AIRg, the increase in plasma insulin above basal 
concentration integrated from 0 to 10 min after glucose dose results from the β cell responsiveness 
to glucose load (Bergman and Lovejoy, 1997) and DI, an index determined by the product of the 
AIRg and SI. A brief process of how minimal model interpret glucose-insulin dynamics is shown in 
Figure 2.4 above where G indicates plasma concentration of glucose; I represents plasma 
concentration of insulin; Sg is glucose effectiveness (i.e., glucose- mediated glucose disposal), and 
X is insulin action (i.e., insulin-mediated glucose disposal). The AIRg represents the acute insulin 
response to glucose in the first 10 min of secretion after glucose infusion, p3 is the contribution of 
plasma insulin to the remote compartment, and p2 is the fractional rate of insulin clearance from the 
remote compartment. Insulin sensitivity (Si) is calculated as p3/p2. In details, glucose effectiveness 
(min−1), the capacity of glucose to mediate its own disposal independent of a change in plasma 
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insulin was calculated using the following equation: 
G′(t) = −(X + Sg) × G(t) + (Sg × Gb) 
where G′(t) represents the rate (min−1) of glucose clearance from plasma; X represents insulin 
action (i.e. the acceleration [min
−1
] of glucose disposal associated with insulin concentration above 
basal); G(t) represents plasma glucose concentration (mg/dL) at time t, with G(0) being the 
theoretical glucose concentration at time 0, as calculated using the minimal model (Bergman et al., 
1979); and Gb represents basal glucose concentration (mg/dL) maintained by hepatic production. 
Insulin sensitivity (L·mU
−1
·min
−1
), the capacity of insulin to promote glucose disposal was 
calculated using the following equations: 
X′(t) = −p2 × X(t) + (p3 × [I(t) − Ib]) 
Si = p3/p2  
where X′(t) (min−2) represents the change in insulin action over time; parameter p2 represents the 
rate (min
−1
) of decline of insulin action; X(t) is insulin action (min
−1
) (i.e., the acceleration of 
glucose disposal at time t associated with insulin concentration above basal); parameter p3 
represents the rate (min
−1
) of introduction of insulin into the interstitial space; I(t) represents the 
insulin concentration (mU/L) at time t; and Ib represents basal insulin concentration (mU/L). 
Assumptions were X(0) = 0 and [I(t) − Ib] = 0 if I(t) < Ib. Acute insulin response to glucose 
(mU·min·L
−1
), which quantifies endogenous insulin secretion in response to the glucose dose, was 
calculated using the following equation: 
AIRg = ∫ [I(t) − Ib] × dt 
where I(t) represents the insulin concentration at time t and Ib represents basal insulin concentration. 
The equation was integrated from 0 ≤ t ≤ 10 min in accordance with the definition of AIRg 
(Bergman and Lovejoy, 1997). The disposition index, an index that describes β-cell responsiveness 
and accounts for the influence of both endogenous insulin secretion (AIRg) and Si, was calculated 
as follows: 
DI = AIRg × Si 
 
In early 1973, the OGTT was used to investigate intestinal absorption in horses. It was subsequently 
found that this may be more suitable for glucose tolerance evaluations (Jeffcott et al., 1986). 
Recently, researchers found that the glucose-dependent insulin secretion is enhanced by the incretin 
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during oral glucose challenge in humans (Vilsbøll and Holst, 2004). In contrast, the incretin effect is 
inhibited in humans by glucose intolerance and obesity (Muscelli et al., 2008). The OGTT is a test 
involving an administration of 1g/kg LW glucose load via nasogastric intubation and frequent 
sampling. A pre-load basal sample is taken and samples are then collected at 15, 30, 45 and 60 min 
and thereafter at 30 min intervals for the following 5 hours (Jeffcott et al., 1986). The benefit of 
OGTT is that the insulin and glucose responses are represented by natural ways. However, the feed 
remaining in the equine stomach may block the entry of glucose liquid into the small intestine, and 
it has been found that food materials may be retained in the stomach after 24 hours fast (Hill and 
Kidder, 1972).    
 
The insulin response curve in OGTT is an overall presentation combining Si, Sg and β cell function. 
In the epidemiological area, fasting plasma insulin is used as an index of IR. Furthermore, the 
plasma insulin curve at 30 min after glucose load, has been considered as an index of β cell function 
(Haffner et al., 1996). The peak value of glucose may be presented at 90 to 120 min after the 
glucose intake and it should return to the base line within 4 to 6 hours (Roberts and Hill, 1973). A 
prolonged glucose curve may be indicative of an impaired β cell function, a lowered Si and an 
abnormal intestinal absorption. The interpretation of OGTT may be divided into two phases. Over 
first 120 min post glucose continuous absorption of glucose from the small intestine, which may 
reach a peak of the double resting glucose value (Roberts and Hill, 1973). The second phase of the 
OGTT is considered to be the last 4 hours when insulin responds to the hyperglycaemia to alter the 
glucose deposition and inhibit the absorption (Roberts and Hill, 1973). The glucose dosage is an 
essential factor in OGTT. As mentioned above, 1g/kg LW glucose is the common rate but the dose 
may be modified for different purposes. A previous study by Roberts (1972) reported that the horses 
given a small quantity dose of 0.5g glucose/kg LW in a 20 precent water solution showed a 
prolonged hyperglycaemic phase after 240 min followed by a return to the base line as has also 
been found in humans (Beckett and Smith, 2005). The glucose quantity and concentrations may also 
be essential during OGTT as its results are highly dependent on the dose as reported in humans 
(Hove et al., 2010). However, this hypothesis may be rejected by the observation that there was no 
difference between OGTT results obtained using 20 or 25 percent solutions in horses (Roberts and 
Hill, 1973).   
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2.4 Body condition score in horses 
It is reasonable to estimate BCS on horses by using the standards used by Henneke et al. (1983) 
which devised a scoring system dependent on palpable fat and visual evaluation of  six regions of 
the horse‟s body with scores ranging from 1 (poor) to 9 (extremely fat, Appendix 1). However, there 
was no significant relation between this evaluated system and fat percentage and live weight in the 
research from Henneke‟s team (Gentry, 2001). Other studies found that there are strong 
relationships between the estimation of back fat thickness measured by ultrasonography (Westervelt 
et al., 1976) and between BCS and back fat thickness (Gentry, 2001). Therefore, Cartmill et al. 
(2003b) suggested that the estimation of BCS should be evaluated by using two methods to correct 
errors. It showed that hyperinsulinemia is closely associated with obesity and BCS. Gero et al. 
(2007) pointed out that insulin content in horses is characterized by BCS. In that study, horses with 
BCS<4, 4-6, 6.5-7 and 7-9 had serum insulin contents at 5.7±0.6, 7.3±0.8, 14.2±1.9 and 27.8±3.1 
mU/L, respectively, which is significantly different. 
2.5 The role of leptin and adiponectine  
Leptin is a protein hormone at 16 kDa originally discovered in adipose tissues where it acts as a 
satiety factor in signaling for whole body energy balance (Trayhurn et al., 1999). In humans and 
animals, leptin has been reported to have an effect on restriction of food intake and to increase 
energy expenditure. Subsequently, leptin has been implicated to reduce the production and secretion 
of insulin by affecting pancreatic β cell function (Henson and Castracane, 2006). Leptin has also 
been identified as an important indicator of adipose mass and nutritional status in many species 
(Buff et al., 2002). Accordingly, leptin may play a role of modulating body fat mass. It has been 
shown to be involved in various aspects such as feed intake, growth, metabolism and reproduction 
(Woods et al., 2000, Barb et al., 1998).  
 
Adiponectin, a 247-aminoacid adipokine synthesized by adipose tissue occurs stably in plasma. 
Arita et al (1999) showed that there was a negative correlation between adiponectine and body fat 
mass in both men and women. Significantly lower blood adiponectine concentrations have been 
found in obese humans compared to non-obese humans (Arita et al., 1999). Therefore, plasma 
adiponectine may be a good biomarker for the evaluation of obesity. Recent research has 
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demonstrated that obese children who began a different diet or increased physical activities showed 
a reduction in adiponectine even though there were no changes in live weight and body composition 
(Cambuli et al., 2008).  
2.5.1 Leptin and body condition 
Current studies regarding leptin have often been carried out in humans and rodents while data from 
specific livestock including horses are rare. A positive correlation between leptin concentrations and 
body mass status has been reported in cattle and sheep (Ehrhardt et al., 2000, Delavaud et al., 2000). 
In humans with obesity, a 10% LW loss can cause a reduction in serum leptin by 50% while a 300% 
increase in serum leptin can be induced by a 10% body mass gain (Houseknecht et al., 1998).  
 
Buff et al. (2002) conducted an experiment to quantify leptin in horses. In this research, it was 
found that the levels of leptin receptors and leptin were increased by equine subcutaneous adipose 
tissues because of the expression of two particular cDNAs which were encoded. Therefore, a higher 
fat mass provides a greater level of leptin secretion and leptin receptors. Leptin receptors are found 
all over the animal‟s body mainly in the liver, lung, muscles, ovary, choroid plexus, hypothalamus 
and subcutaneous adipose tissues. 
 
Buff et al. (2002) suggested that the relationship between BCS and serum leptin levels (Henneke et 
al., 1983) can be considered as BCS +1 = leptin + 1.11+0.57. However, leptin levels may not be 
sensitive to the changes in BCS. In the experiments carried out by Buff et al. (2002), ponies were 
divided into a fat-restriction (feed restriction) group and a thin-supplement group with one group 
being fed to cause a decrease in BCS loss and the other group being fed to increase BCS over a 
period of 14 weeks of observation. It was found that although BCS and LW decreased by two scores 
in the fat-restriction group and increased by two scores in the thin-supplement group, the changes in 
the levels of serum leptin were not significantly different even through the fat restriction group 
apparently had a higher level of serum leptin than the thin-supplement group did. A change in BCS 
achieving more than two scores may be required to cause a significant change in serum leptin levels 
even through Kearns et al. (2006) also illustrated a positive correlation between body fat and serum 
leptin concentrations. It has not been known that what variation occurs between ponies and horses 
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in terms of leptin.  
 
Although a positive correlation between fat mass and leptin levels was determined (Gentry et al., 
2002), Gentry et al. (2002) presented conflicting results indicating that mares with the same body 
conditions may have widely variable leptin concentrations. However, this may have been due to all 
mares in this research not being in the breeding season (September, Northern hemisphere). Cartmill 
et al. (2003b) supported this point of view and showed that mares and geldings had different leptin 
levels although they were of similar BCS (average 7.5). One-third of the mares showing 
hyperleptinaemia were related to the herd mates with similar BCS (Huff et al., 2008). This seemed 
to indicate that not all non-pregnant mares with high body conditions will suffer hyperleptinaemia. 
 
Leptin has also been reported to have a crucial role in pregnancy. It appears that leptin affects the 
successful rate of fertilization, placental development, the regulation of puberty and maintenance of 
pregnancy (Ceddia et al., 2002, Henson and Castracane, 2006). More importantly, placental leptin 
contributes to the increase in maternal circulating leptin during late pregnancy to regulate the 
energy metabolism balance. It has also been noted that leptin levels have a correlation with neonatal 
and placental weight in humans (Schubring et al., 1997). Leptin of both placental and maternal 
origin can be bound to the same leptin receptors. However, it is difficult to identify the role of each 
source of leptin in late pregnancy. It is known that once leptin is bound to leptin receptors, the 
function of this combination can directly contribute to the peripheral function (Myers et al., 2008). 
2.6 The third trimester of pregnancy in horses 
Generally, pregnancy in mares can be divided into two periods: the first eight months and the last 
three months. These are followed by a period of lactation (Frape, 2004). Nutritional requirements 
by pregnant mares are greatest during late pregnancy, when most of the foetal growth occurs, and 
lactation (Kane, 2006). However, different energy and protein contents were required in feeding 
during late pregnancy where the mares are often required to draw upon stored reserves to maintain 
intrauterine growth of the foetus. Renaudin et al. (2000) has pointed out that nutrition in early 
pregnancy is also important because of the malabsorption syndrome. A live weight loss during late 
pregnancy and lactation is of more concern to the owner due to the need of maintaining the mare‟s 
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body conditions for the subsequent breeding season. Therefore, additional energy resources may be 
added to the mare‟s diet during late pregnancy to maintain or increase the BCS. Bell et al. (1999) 
indicated that Si decreases in late pregnancy to increase the levels of blood glucose and to support 
foetal development in humans. A similar syndrome of IR has been reported in mares at 270 days of 
gestation (Fowden et al., 1984b). Although peripheral insulin insensitivity can be a factor that slows 
down the clearance of glucose into maternal tissues and to ensure the bioavailability of glucose 
thatsupports foetoplacental tissues, low Si may result in an energy imbalance in the mare (Clapp, 
2002). 
2.7 Dietary induced obesity in mares 
Dietary management should be designed for specified purposes such as avoidance or prevention of 
diseases and promotion of performance. In the case of IR, high carbohydrate is the main factor 
affecting mares. Pagan (2005) described different grain sources and processing methods which may 
cause varying glucose and insulin responses in horses (Pagan 2005). McGowan et al. (2008) 
reported that pregnant mares fed with high forage may have a lowered basal insulin concentration. 
In contrast, high energy diets such as high starch or non-structural carbohydrates have significant 
effects such as an increased BCS in mares during the last trimester of pregnancy (Dobbs et al. 2011). 
Moreover, George et al. (2009) indicated that a high starch diet fed to mares during late pregnancy 
may also have an effect on their foals. Others have reported a contrary view that the neonatal foal 
naturally has IR due to the development of the pancreas at this age (Fowden et al., 2005, Holdstock 
et al., 2004). 
 
In relation to glucose tolerance tests, it has been found in previous studies that dietary history in 
humans may affect the result of glucose tolerance tests due to the abundant glycogen deposits in 
liver and muscle tissues (Beckett and Smith, 2005). A sudden restricted low carbohydrate diet 
without a dietary history check may result in a diabetic tolerance curve which has been reported in 
humans (Beckett and Smith, 2005) and dogs (Hill and Kidder, 1972).  
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3.1 Introduction 
Based on the studies reviewed in Chapter 2, it is apparent that body composition/condition 
influences the metabolic responses of females from different species to the physiological changes 
that occur during pregnancy. These relationships are poorly described in the horse. In previous 
studies in this laboratory (Dobbs et al. 2012), demonstrated that feeding a high energy diet to mares 
in the last trimester of pregnancy increased basal insulin and glucose concentrations, but did not 
affect Si, Sg, or β cell responsiveness. However in that study, only small differences in live weight 
and body condition were obtained. The present experiment was therefore conducted to determine if 
pregnant mares with disparate BCS had differences in insulin-glucose responses. The FSIGTT was 
used and examined by the minimal model method. Dietary management was performed to ensure 
significant differences in BCS between two groups of pregnant mares.  
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3.2 Experimental design and protocol  
The experiment described in this chapter was undertaken and performed with the approval of the 
University of Queensland Animal Ethics Committee and complied with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes 
3.2.1 Horses 
Thirteen Standardbred (n=11) and Thoroughbred (n=2) mares aged 4 – 13 years were mated to the 
same Australian Stock Horse stallion and ovulation dates recorded. Following a positive pregnancy 
test at GD 45 (GD 0 = day of ovulation) the mares were turned out into the one paddock. All mares 
were maintained on the same pasture and subjected to the same management procedures until the 
commencement of the experiment. 
 
At the start of the experiment, during mid-gestation (day 250 of gestation approximately) the mares 
were evaluated for BCS and then allocated into two groups, high body condition score (HBCS, n=6) 
and low body condition score (LBCS, n=7). Mares were allocated to the groups depending on BCS. 
The range of BCS at group selection was from 3 to 7. The mares were allocated to groups to obtain 
a HBCS group (average 6.5) versus LBSC (average 5.0) group (Figure 3.1).  
3.2.2 Dietary management  
The mares were then placed into adjoining paddocks and feeding of the treatment diet commenced. 
Mares were rotated from one pasture to the other each fortnight to ensure that both groups were 
exposed to similar pasture. Mares in both groups were fed a 2 kg of a concentrate feed (Pryde‟s 
Biomare Cubes) twice a day. Mares in the HBCS group were fed an additional energy supplement 
(steam flaked barley, 0.5kg) twice a day. All diets were offered individually in the morning (before 
08:30 hours) and the afternoon (between 16:00 and 17:00 hours). These diets were balanced for 
minerals based on NRC recommendations (2007) to achieve the nutrient requirements of late 
pregnancy in mares. Moreover, the digestible energy （DE）, the diet for LBCS groups was 100% of 
the pregnant mare daily dietary DE requirement referred to NRC recommendations (2007). In 
contrast, the feeding of steam flaked barley to HBCS mares increased the DE concentration of their 
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diet to 150% of DE requirements. The components of the diet fed to both groups are shown on 
Appendix 2. 
 
The purposes of using this dietary design were to maintain the mares at either a light-moderate BCS 
(BCS 3 to 4) or to increase their BCS to achieve a high value (BCS 6 to 8). Evaluations of BCS 
were conducted weekly to ensure the gap of BCS between the two groups and the diets were 
adjusted accordingly. Extra energy supplements were added to LBCS mares if their BCS fell below 
3 to ensure that the health of the mare and foetus was not adversely affected. Likewise, the steam 
flaked barley was removed from HBCS mares if their BCS increased above 9 to ensure the health of 
the mare and foetus. All mares were transferred to individual yards in the last week of pregnancy 
and fed 3.5 kg barley hay and 2 kg concentrations (Pryde‟s Biomare Cubes) twice a day until 
parturition. 
 
  
Figure 3.1: Body condition score at the date of grouping. A significant higher BCS was observed in 
the HBCS groups (P<0.05) as assessed using one-way ANOVA t test. 
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3.2.3 Body condition evaluation 
The Henneke system of BCS was used (Henneke et al., 1983). In this system, the classification of 
BCS ranges from 1 (poor) to 9 (extremely fat) (Appendix 1). The mares were allocated to their 
groups based on BCS. Mares in the LBCS group were maintained at a BCS between 3 and 4 (thin to 
moderately thin). Mares in the HBCS group were fed to achieve and maintain a BCS from 6 to 8 
(moderately fat to fat). Weekly BCS evaluation was conducted from GD 280 to ensure there was a 
significant gap of BCS between two groups.  
3.2.4 Blood sampling timeline 
Blood samples were collected from the external jugular vein in both mares and foals. Samples were 
collected using (10ml BD-Plymouth. PL67BP.UK) and a 20G needle for mares and by using a 
suitably sized syringe for foals and umbilical cord. All blood samples were centrifuged (3500rpm, 
10min,), the plasma decanted and stored at -20℃. The timelines for sample collection are shown on 
Figure 3.2 where FISIGT were conducted on day 290 and day 320 of gestation. In addition, blood 
samples were collected weekly via the external jugular vein from week 41 of gestation until week 
46 (one week after Day 320 FSIGTT) in all mares. Collections were conducted before morning 
feeding (8:30am) in the paddock and were stored on crushed ice until centrifuged and the plasma 
was frozen for further assays.  
 
Figure 3.2: Time lines of blood sample collection (Weekly samples were taken from mares from 
week 41 to week 46 of gestation, FSIGTT were conducted on mares at days 290 and days 320 of 
gestation.)   
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3.2.5 Frequently Sampled Intravenous Glucose Tolerance Test  
Mares in both groups underwent an FSIGTT at GD 290 and GD 320. Mares were fasted from 
5:00pm of the day prior to testing to avoid diet having a confounding effect. Each mare was 
weighed immediately prior to performing the FSIGTT to allow calculation of the dose of insulin 
and glucose to be administrated. Following surgical preparation, catheters were placed in both the 
left and right external jugular veins. The glucose and insulin were administered via the right jugular 
catheter and all blood samples were collected from the left jugular catheter. Following the initial 
blood collection (Time 0), glucose was rapidly (within 2 and half min) injected at a dose (dextrose 
solution 50% w/v) of (0.3*LW (Kg))/2 and blood samples were collected every minute for 6 min 
then every second minute until 16 min. Another blood sample was taken at 19 min and this was 
followed by the insulin (Elili Lilly Aust/Humalog) injection (0.2*LW (kg)/100) at 20 min. This 
insulin dose was equivalent to 0.02 international units per kilogram of LW (IU/kg/LW). Blood 
sampling was then continued every minute from 22 to 27 min then at increasing intervals until 240 
min (4 hours) after the initial injection. Further details of sampling times appear in Appendix 3. 
Mares were fed hay after of was taken at 30 min sample. Blood glucose concentration was 
determined at the time of sample collection using a glucometer (TrueTrack, Nipro Diagnostcs Inc, 
Osaka, Japan).The blood samples were then centrifuged and the plasma frozen at -20℃for further 
assays.  
 
The catheterization was applied prior to the FSIGTT. All operators wore sterile gloves. The areas 
around the left and right external jugular veins were shaved and cleaned using chlorohexidine 
solution and an alcohol swab to avoid the risk of contamination. Prilocaine
TM
 (2ml) was applied to 
each site to affect local anaesthetic. Then, an angiocath (16 gauge, 5 ¼ inch) catheter, associated 
with extension sets (6 inch), was inserted into each vein and secures with super-glue and elastoplast. 
Both catheters and extension sets were flushed with heparinized saline (5,000 IU/L) to ensure they 
were fluent.  
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3.2.6 Minimal model analysis 
Data for glucose and insulin (the assay methods will be described below) collected during the 
FSIGTT were calculated by the MINMOD Millennium computer program as described by Boston 
et al. (2003). The outputs from such program were included Si, Sg, the AIRg, DI, the contribution 
of plasma insulin to remote compartment (P3) and the fractional rate of insulin clearance from the 
remote compartment (P2) (Bergman et al., 1987). The descriptions of these compartments appear in 
Chapter 2.  
3.2.7 Insulin assay  
Plasma insulin concentrations were measured using a commercial human radioimmunoassay kit 
(Coat-A-Count Insulin RIA kit; Siemens Healthcare Diagnostics Ltd, Los Angeles, CA), which 
previously has been validated for use in horses (Tinworth et al. 2009). The assay was performed 
according to the manufacturer‟s instructions, with incubation of standards, quality controls or 
samples (200µl each), with tracer (1.0mL of 125I Insulin) into antibody coated tubes, vortexed and 
stored for 24 hours at room temperature. All tubes were then decanted and counted on a gamma 
counter the next day. For measurement of high insulin concentrations during the FSIGTT after the 
insulin injection, samples from 22 (T22) to 50 min (T50), were diluted 1:10 in charcoal stripped 
foetal calf serum.  
3.2.8 Leptin assay 
Plasma leptin concentrations were determined using the commercial Multi-species leptin RIA kit 
(Millipore, Cat. # XL-85K) that has been used previously on equine blood samples (Cartmill et al. 
2003). The assay was performed according to the manufacturer‟s instructions, with standards, 
quality controls, or samples (100µl), being incubated with 100 µl assay buffer (0.05M phosphate 
buffered saline, pH7.4 with 0.025M EDTA , 0.08% sodium azide, 0.05% Triton X-100 and 1% RIA 
grade BSA) and 100µl primary antibody (guinea pig anti-leptin) overnight at 4℃. The next day, 
100µl of tracer (
125
I-human leptin in label hydrating buffer containing normal guinea pig IgG as 
carrier) was added to all tubes, vortexed and stored again overnight at 4℃. One ml of precipitating 
reagent (goat-anti guinea pig IgG serum with 3% PEG. 0.05% Triton X-100 in 0.05M phosphate 
31 
 
buffered saline with 0.025M EDTA) was then added and incubated for 20 min at 4℃, followed by 
centrifugation (3000rpm, 20min, 4℃). Tubes were then decanted and the remaining pellet counted 
using a gamma counter.  
3.2.9 Statistical analysis  
A one-way ANOVA was performed to compare between the groups in terms of BCS and other 
parameters from minimal model analysis. All analysis was conducted using Minitab
®
 16.1.0 
software at a 95% confidence level and all values were expressed as means ± SEM.  
3.3 Results 
3.3.1 Body condition and leptin 
Weekly BCS values were significantly higher (P<0.05) in the HBCS group compared to the LBCS 
group during late pregnancy (weeks 41 to week 46). Moreover, there was a significant BCS by time 
interaction (P<0.05) where BCS in the HBCS group increased, whilst values in the LBCS group 
decreased over time during late pregnancy (Figure 3.3). Live weight of mares was measured less 
frequently over late pregnancy. However, there was no significant difference between the mare 
groups, nor any significant change over time (Figure 3.4).  
 
Notably at the time of the FSIGTT were conducted (GD 290 and GD 320), there were no significant 
(P>0.05) differences in LW between HBCS and LBCS mares. However, as expected BCS was 
significantly (P<0.001) higher in HBCS mares than LBCS mares (Table 3.1) and there was a 
significant (P<0.05) group by time interaction for BCS. In the HBCS group BCS significantly 
(P<0.01) increased between GD 290 and GD 320, whereas in LBCS group BCS significantly 
(P<0.01) decreased over these days. In comparison, no significant changes over time were observed 
for LW. During the last 6 weeks of gestation there were significantly different (P<0.01) plasma 
leptin concentrations between the mare groups (Figure 3.5), with leptin concentrations being higher 
in the HBCS mare group. However, within each group leptin concentrations did not significantly 
change over time (P>0.05).  
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Table 3.1: Body condition score and live weight at the times of performing the FSIGTT  
 
BCS 
 
LW (kg) 
 
 
HBCS LBCS HBCS LBCS 
Day 290 6.3 ± 0.4
a
 4.1± 0.3
b
 513.4 ± 24.9
a
 523.9 ± 15.9
a
 
Day 320 7.2 ± 0.5
c
 3.3 ± 0.3
d
 543.2 ± 27.3
a
 526.9 ± 14.7
a
 
All data are shown are means ± SEM. Different superscripts denote a significant (P<0.01) differences between 
means, either between HBCS and LBCS groups (rows) or between days (columns). 
 
 
Figure 3.3: Weekly BCS of high and low BCS mares during late pregnancy. Data presented by are 
means ± SEM. Significant differences (P<0.05) between groups as determined by one-way 
ANOVA are shown using different superscripts 
ab
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Figure 3.4: Live weight changes during last trimester of gestation. Data presented are means ± 
SEM. No significant difference was found between groups or over time (P>0.05).  
 
Figure 3.5: Weekly plasma leptin concentrations of HBCS and LBCS mares during late pregnancy. 
Data represented are means ± SEM. Values bearing different superscripts differ significantly 
(P<0.05).  
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3.3.2 FSIGTT (GD 290 and GD 320) and minimal model  
The FSIGTT was planned to be performed on GD 290 and GD 320 for all mares. However, due to 
adverse weather conditions, building construction around the experimental facility, and possible 
animal stress effects, the actual dates of performing the FSIGTTs were variable (Table 3.2). 
However there was no significant difference in timing of the FSIGTT between groups. Basal insulin 
and glucose concentrations were not significantly different between HBCS and LBCS groups on 
either day 290 or day 320 when FSIGTT were performed (Table 3.3). In contrast, the leptin 
concentrations were significantly different (P<0.05) between groups on both day 290 and day 320 
as expected (Table 3.3). Basal insulin, glucose and leptin concentrations were not significantly 
changed over time in either group.  
 
Table 3.2: Timing of FSIGTT during late pregnancy 
Planned GD Actual GD of FSIGTT 
 HBCS LBCS 
GD 290 GD 294 ± 1.1 GD 293 ± 1.1 
GD 320 GD 321 ± 0.3 GD 321 ± 0.3 
Data in this table are represented are means ±SEM.  
 
Table 3.3: Basal plasma concentrations of insulin, glucose and leptin at day 290 and day 320 of 
gestation 
 
Insulin 
(mIU/L) 
 
Glucose 
(mg/dL) 
 
Leptin 
(ng/ml) 
 
 
HBCS LBCS HBCS LBCS HBCS LBCS 
Day 290 11.5 ± 5.5 3.7 ± 2.0 93.7 ± 4.8 83.7 ± 3.4 2.5±0.5
a
 1.1±0.2
b
 
Day 320 4.7 ± 1.9 4.3 ± 1.0 81.1 ± 7.4 83.7 ± 3.5 2.7±0.9
a
 1.1±0.1
b
 
Data shown are means ± SEM. Significant difference was found on leptin between groups at either at 290 or day 
320. 
 
The optimal result for investigating insulin and glucose dynamics via a FSIGTT test is via the 
minimal model analysis, which is described in next section. Interpretation of the FSIGTT hormonal 
profiles provides an overall view of the insulin and glucose changes during glucose and insulin 
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challenges. In this Section, results are divided into these two phases: glucose challenge (first 19 min 
post i.v. glucose injection), and insulin challenge (time 22 to 240 min post i.v. insulin injection). In 
the first phase (glucose challenge) of the FSIGTT at GD 290 plasma glucose concentrations as 
expected, changed over time. There was an overall significant (P<0.001) difference between groups 
(Figure 3.6), with LBCS mares exhibiting less glucose clearance than HBCS mares. However there 
was no significant interaction between BCS groups over time at GD 290. Plasma insulin responded 
to the glucose challenge in first phase as illustrated in Figure 3.7. There was an overall significant 
(P<0.001) effect of BCS group with lower insulin secretion in LBCS mares, but no significant 
interaction between BCS group by time on this gestational day. However, marked variation of the 
insulin secretion within each BCS group was also noted. Some animals in LBCS group exhibited 
minor insulin secretion at GD 290.  
 
Figure 3.6: Plasma concentrations of glucose during the first phase of FSIGTT at day 290 of 
gestation. Data represented are means ± SEM. A significant effect of time and BCS group was 
detected. Data bearing superscripts ** indicates significant difference between groups at the time 
point. 
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Figure 3.7: Plasma concentrations of insulin at the first phase of FSIGTT at day 290 of gestation. 
Data represented are means ± SEM. A significant effect of BCS group as detected. A significant 
difference between groups at shown by data bearing superscripts * at indicated time points. 
 
In the second phase (insulin challenge) of the FSIGTT at GD 290, plasma concentrations of glucose 
as expected declined over time in response to the insulin injection (Figure 3.8). At this gestational 
day there was an overall significant effect of BCS (P<0.001) and interaction of BCS group with 
time (P<0.01). The insulin mediated glucose uptake was higher in HBCS than LBCS mares and 
significant differences were found at various time points after insulin injection. Insulin 
concentrations declined over time and there was a significant (P<0.001) BCS by time effect (Figure 
3.9) 
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Figure 3.8: Plasma concentrations of glucose during the second phase of FSIGTT at day 290 of 
gestation. Data represented are means ± SEM. A significant effect of time versus group was 
detected on this line graph. A significant difference between groups at shown by data bearing 
superscripts ** at indicated time points.  
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Figure 3.9: Plasma insulin concentrations during the second phase of FSIGTT at day 290 of 
gestation. Data are represented by means ± SEM. Significant effect of time versus group was 
detected on this line graph. Data bearing superscripts ** indicates significant difference between 
groups at the time point.  
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Figure 3.10: Plasma concentrations of glucose during the first phase of FSIGTT at day 320 of 
gestation. Data represented are means ± SEM. A significant effect of time and BCS and an 
insignificant effect of time versus group were found. Data bearing superscripts ** indicates 
significant difference between groups at the time point.  
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Figure 3.11: Plasma concentrations of insulin during the first phase of FSIGTT at day 320 of 
gestation. Data are represented by means ± SEM. Significant effect of time and BCS and 
insignificant effect of time versus group were found. Data bearing superscripts ** indicates 
significant difference between groups at the time point.  
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mares (Figure 3.13). However there was no significant interaction between BCS group and time 
(P>0.05).  
 
Figure 3.12: Plasma concentrations of glucose during the second phase of FSIGTT at day 320 of 
gestation. Data are represented by means ± SEM. Significant effect of time versus group was 
detected on this line graph. Data bearing superscripts ** indicates significant difference between 
groups at the time point. 
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Figure 3.13: Plasma concentrations of insulin during the second phase of FSIGTT at day 320 of 
gestation. Data represented are means ± SEM. A significant effect of time and BCS and an 
insignificant effect of time versus group were found. Data bearing superscripts ** indicates 
significant difference between groups at the time point. 
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Table 3.4: Insulin clearance at the second phase of the FSIGTT at day 290 and 320 of gestation in 
mares with high (HBCS) and low (LBCS) condition scores.  
 Day 290 Day 320 
 HBCS LBCS HBCS LBCS 
Slope -0.04±0.02 -0.03±0.01 -0.04±0.02 -0.03±0.01 
Intercept 
Half-life 
7.0±2.9 
17.1±7.0 
6.7±2.5 
19.8±7.5 
7.0±2.9 
16.7±6.8 
6.7±2.5 
20.4±7.7 
All data are shown in this table are means ± SEM. No significant differences were found between groups or over 
time in each parameter (P>0.05).  
 
Table 3.5: Minimal model result at days 290 and 320 of gestation in mares of high (HBCS) and low 
(LBCS) scores.   
 Day 290 Day 320 
Variable HBCS LBCS HBCS LBCS 
Si 
(x10-4L.mU-1.min-1) 
0.94 ± 0.11
a
 0.22 ± 0.14
b
 1.07 ± 0.35
a
 0.10 ± 0.06
b
 
Sg  
(x102/min ) 
0.019 ± 0.002 0.021 ± 0.002 0.022 ± 0.004 0.018 ± 0.002 
AIRg 
(mU.min.L-1 ) 
255.8 ± 62.6
ac
 163.8 ± 79.0
a
 347.53 ± 60.8
c
 80.3 ± 24.1
b
 
DI 
(x10-2 ) 
226.7 ± 57.1
a
 33.9 ± 28.8
b
 282.9 ± 79.7
a
 4.3 ± 2.7
b
 
All data are shown on this Table as means ± SEM. Data with different superscripts are a significantly (P<0.05) 
different between groups or time.  
Results derived from minimal model analysis of the FSIGTT data are shown in Table 3.5. The Si of 
LBCS mares was significantly (P<0.01) lower on both day 290 and day 320 of gestation compared 
to HBCS mares. Moreover, Si significantly declined from GD290 to GD320 in LBCS mares, to an 
average of 0.1 on GD320. The acute response of insulin to glucose (AIRg) was similar between the 
mare groups on day 290, but was significantly (P<0.01) lower on day 320 of gestation in LBCS 
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mares compared to HBCS mares. The DI accordingly was significantly (P<0.01) lower in LBCS 
mares compared to HBCS mares at both GD290 and GD320. In contrast, Sg was not different 
between groups at any time. 
3.3.3 Mare birth and placenta weight 
Each mare delivered a live, healthy foal. All foals consumed colostrum within 30 min of birth and 
none showed failure of passive immunoglobulin transfer. Mares foaled within 11 days from 
predicted due days, except one mare in the HBCS group which gave birth 45 days later than the 
predicted due date. The placentas from LBCS mares were significantly (P<0.05) heavier than those 
of the HBCS mares (5.5 ± 0.3 versus 3.8 ± 0.2 kg respectively). 
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3.4 Discussion  
There was a remarkable difference between the BCS groups. Low BCS mares suffered from severe 
IR and diminished pancreatic β cell function. In a previous study by Dobbs et al. (2013), there was 
no significant difference in insulin sensitivities between mares fed with high and low energy diet, 
and the gap between the groups (3.7 ± 0.1 vs 4.0 ± 0.0 at day 320 of gestation) was not large based 
on the BCS standard (Henneke et al. 1983). Although the high energy diet did not affect Si, it 
appeared that feeding a high energy diet increases the BCS during last trimester of gestation in 
mares. Therefore, the purpose of the present experiment was to make the difference in BCS between 
two groups more significant to investigate whether obese mares suffered from IR. The treatment 
diet was started commencing at approximately day 230 of gestation (the last trimester of gestation). 
The mares had been maintained on the same pasture and the same diet management before the 
commencement of the trial. Therefore, the mares in the HBCS group had no tendency to be „fatter‟ 
than those of the LBCS group at the commencement of the study. From the results shown, a 
significant difference between groups was successfully achieved by the designed diets with a 
significantly higher BCS in HBCS mares compared to LBCS mares. This is consistent with the 
dietary energy intake in the HBCS group exceeding the demands for growth by the foetoplacental 
unit allowing excess energy to be stored by the mares as fat (Clapp, 2002).   
The nutrient requirements for mares in the last three months of gestation are higher than those of 
non-pregnant mares or mares in early pregnancy (Frape, 2004). For this reason, a high energy diet 
in the last trimester of gestation may cause metabolic or hormone impacts on mares and may affect 
their developing foals (Clapp, 2002, George et al., 2009). From a previous study, it is known that 
feeding a diet with high non-structural carbohydrates (NSCs) content can affect Si in horses 
(Kronfeld et al., 2005). However, Dobbs et al. (2013) indicated that such diets can cause a 
significant BCS increase in mares during the last gestation but cause no significant change in 
insulin sensitivities. In the present study, the significant difference between the HBCS and LBCS 
groups was achieved by feeding a high energy diet to the HBCS group ensuring that they reached a 
BCS of 7 to 8 which was significantly higher than that of the LBCS group (BCS 3 to 4). According 
to the National Research Council (2007), pregnant mares are expected to have an up to 15% 
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increase in the initial LW during pregnancy. Dobbs (2013) indicated the major LW gain occurs 
between days 230 and 290 of the gestation. This has been confirmed in the present study where 
mean LW in the HBCS group increased from 513 kg at day 290 to 543 kg at day 320, an 
approximately 6% increase from the initial LW. Lawrence et al. (1992) considered that mares may 
alter body stores during late pregnancy resulting in no significant LW change. In the present study, 
interestingly the LWs of the mares were not significantly different between the groups in this 
experiment even though the BCS was significantly different between the groups. This disparity may 
have been due to the different sizes of the mares within the groups. There were 2 Thoroughbred 
mares in the LBCS group while all other mares were Standardbreds (n=10; LBCS n=5, HBCS n=6). 
The Thoroughbred mares are generally taller and larger framed than the Standardbred mares in 
accord with usual genetic variation between breeds. On the other hand, this may suggest that the 
BCS system demonstrated by Henneke et al. (1983) is less accurate when excluding physical 
measurements such as height and length.  
The plasma concentration of leptin during the last trimester of gestation was significantly higher in 
HBCS mares than in LBCS mares. This observation is in accordance with the results obtained by 
Buff et al. (2002) that horses with a higher body fat content produce more leptin. Although there is 
some evidence indicating that the equine placenta can produce leptin, with mRNA expression being 
recently detected in mare‟s placenta (Chavatte-Palmer et al., 2010). However, the expression of the 
mRNA is extremely low compared to that in humans. Therefore, placental leptin may have some 
minor effects on the present result. Instead, the relatively higher level of leptin in the HBCS group 
as compared to LBCS group is considered to be due to the greater amount of adipose tissue. 
Interestingly, the variability in leptin concentrations in the HBCS group was greater than that in the 
LBCS group. Cartmill et al. (2003a) demonstrated that plasma leptin concentrations are highly 
variable in geldings with the same BCS. Moreover, it was also found that the present system of BCS 
evaluation was less accurate for obese horses (Dugdale et al., 2012). Dugdale et al. (2010) showed 
that three months of dietary restriction resulted in a significant LW loss in ponies, despite a little 
change in BCS. Moreover, a non-linear correlation between experimental results of body fat and 
estimated total body fat also was found in this previous research, where large changes in body fat 
content were accompanied by lesser BCS changes (Dugdale et al., 2010). Therefore, further studies 
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are required to improve the accuracy of BCS assessment with other methods. Weekly mean leptin 
values tended to increase during the last 2 weeks of gestation in both groups in the present study. 
Similar results have been presented by Romagnoli et al. (2007) with a peak in leptin levels being 
detected in the last week of gestation. This may be due to preparation for parturition when the 
placenta contributes a great amount of leptin to regulate nutrient balance between the mare and its 
foetus (Spicer, 2001). 
Pregnancy is characterized by slight IR, with glucose being direct to support foetal growth (Bell et 
al., 1999). This research also found that there were no significant difference in basal insulin 
between pregnant and non-pregnant mares although there was a significant increase in insulin 
concentration in the pregnant mares after feeding, which became more pronounced as pregnancy 
progressed. Women may suffer from GDM during pregnancy (Fathi, 2006), which has the 
characteristic of severe IR. Severe IR has been reported in mares at 270 days of gestation (Fowden 
et al., 1984a). However, this finding was based on a prolonged (infusion 6 hours) period with an 
oral glucose tolerence test and did not show features of β cell failure. In the present study, mares in 
the LBCS group were demonstrating IR at GD 290 compared to HBCS mares. The first phase of the 
FSIGTT characterizes the response to glucose load and therefore involves glucose clearance and 
insulin secretion. Despite the basal glucose and insulin concentrations being similar in both groups 
of mares, the HBCS group presented with lower mean glucose concentrations from two minutes 
after glucose injection and higher mean plasma insulin concentrations compared to the LBCS group. 
This indicates that there was better glucose clearance in HBCS mares in part due to the generally 
higher insulin concentrations. In contrast, a lower insulin level and a higher glucose level in the 
LBCS group were consistent with the total amount of insulin secretion not being “fully” sufficient 
to control glucose and in turn resulting in a higher peak glucose value. From minimal model 
analysis of this data, similar values of Sg were measured at GD 290, consistent with the idea that 
glucose uptake via non-insulin dependent glucose transporters is similar in both BCS groups due to 
the glucose concentration gradient. Moreover, there was an insignificant difference in AIRg (the 
amount of insulin secretion from β cells in response to glucose) between the mare groups at GD 290. 
Despite the mean value of AIRg in the LBCS group being approximately 35% lower than that in the 
HBCS group, there was much variability between animals within each group as shown in Figure 3.7. 
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However it should be noted that minimal model analysis examines responses for each animal 
individually and some animals in the LBCS group appeared to have minimal insulin secretion in 
response to the glucose load at this day of gestation. During the second phase of FSIGTT, glucose 
was cleared rapidly in response to exogenous insulin injection. A more pronounced glucose 
clearance was observed in the HBCS group as shown in Fig 3.8, even though the glucose 
concentrations were similar at insulin injection. Moreover, as shown in Figure 3.9 and Table 3.4, the 
values for intercept and slope representing insulin clearance and metabolism were not significantly 
different between the groups irrespective of glucose. Therefore, the decreased glucose response to 
exogenous insulin in LBCS mares is indicative of insensitivity to insulin. The Si value from 
minimal model analysis confirms this idea, with a very low Si (<0.3) in the LBCS group. In 
conclusion, data from FSIGTT and minimal model analysis at GD 290 were interpreted as evidence 
for reduced glucose clearance and insulin insensitivity in LBCS mares as compared to HBCS 
mares.  
At day 320 of gestation, during the first phase of the FSIGT the glucose concentration in plasma 
peaked at similar values one min after glucose load and exhibited a similar glucose clearance over 
time between BCS groups, when one examined mean data (Fig 3.6) Moreover, from minimal model 
analysis the Sg was similar in both groups (Table 3.5), consistent with similar non-insulin 
dependent glucose transport in both groups. However, despite no difference in basal insulin values，
the secretion of insulin was significantly lower in the LBCS compared to HBCS mares, as shown in 
Figure 3.7. Indeed the mean AIRg from minimal model analysis of individual data confirmed that 
the LBCS group at GD 320 was only one quarter of the HBCS group. Overall this suggests the 
secretion of insulin from β cells was deficient in LBCS mares. In the second phase of the FSIGT at 
day 320, there was a marked decrease in glucose clearance in response to exogenous insulin in 
LBCS mares (Fig 3.12), although insulin metabolism was not different between the groups (Fig 
3.13, Table 3.4). Insulin insensitivity in LBCS mares was confirmed in minimal model analysis with 
a significantly lower Si (<0.1) in LBCS mares at GD 320, which can be considered as severe IR. 
Therefore, the LBCS group at GD320 exhibited severe insulin insensitivity (as determined by low 
glucose response to insulin) and β cell failure (low insulin response to glucose), compared to the 
HBCS group. Interestingly even though the BCS in the present study were similar to those reported 
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by Dobbs (2013), a significantly lower Si (0.1 ± 0.1 vs. 1.1 ± 0.2), Sg (0.018 ± 0.002 vs. 0.022 ± 
0.002) and DI (4.3 ± 2.7 vs. 224.3 ± 133.9) were found in LBCS mares in present study, which 
means the mares with low BCS in the present study had more severe insulin insensitivity and β cell 
failure. Moreover, the HBCS groups showed a similar Si (1.1 ± 0.4 vs. 1.2 ± 0.4), Sg (0.022 ± 0.004 
vs. 0.020 ± 0.006) and DI (282.9 ± 79.7 vs. 250.3 ± 106.3), but a higher AIRg (347.53 ± 60.8 vs. 
191.5 ± 76.2) compared to Dobbs‟ mares with BCS averaging at 3.8. The higher AIRg in the present 
study suggests that HBCS mares are secreting more insulin in response to a glucose load. According 
to the features of GDM in women, the LBCS mares in present study were considered to 
demonstrate GDM. Similarly it was found that lean women are more likely to develop GDM as 
compared to women at a normal weight (Kautzky-Willer et al., 1997). 
Although the overall data are consistent with severe insulin insensitivity in the LBCS group, one 
mare from the HBCS group was found to have an extremely low Si (<0.01) during GD 320. This 
mare had a BCS of greater than 9 according to the evaluation record. Therefore, it is possible that 
mares with BCS less than 4 or those over 9 may be at risk of developing severe insulin insensitivity 
during late pregnancy. In contrast, mares with moderate BCS (5 to 8) may have less risk of 
developing severe IR during pregnancy. According to research in women, both obese and lean 
women have risk of developing GDM during pregnancy (Kautzky-Willer et al., 1997, Getahun et al., 
2010). Therefore, it appears that the current evaluation system of BCS may not cover the range of 
horses with extreme obesity levels. 
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4.1 Introduction 
In women, GDM often is characterized by insulin insensitivity, β cell failure and increased risk of 
developing GDM in a subsequent pregnancy or diabetes in the future. Buchanan et al. (1990) 
indicated that GDM patients may show normal Si during pregnancy, suggesting β cell failure rather 
than severe insulin insensitivity is the defining characteristic of GDM. In contrast, severe IR is 
considered to cause insufficient β cell function which increases the risk for future glucose 
intolerance, as manifested by maternal diabetes or by recurrent GDM in subsequent pregnancies 
(O'Sullivan, 1991). In the previous experiment reported in Chapter 3, significantly lower Si and β 
cell failure (AIRg) were found in mares with low BCS during the last trimester of pregnancy.  
Therefore, it was valuable to investigate whether impaired β cell function occurred in LBCS mares 
in their subsequent pregnancy. Moreover, it was also interesting to examine previous HBCS mares 
in the subsequent gestation when their body condition was more normal.  
 
The OGTT has been used as a simple test to determine GDM in women for many years. The 
advantage of an OGTT is that glucose-dependent insulin secretion can be enhanced by incretin from 
the intestine (Vilsbøll and Holst, 2004). Musceli et al. (2008) found that in obese patients there is a 
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lowered influence of incretin on insulin during a glucose challenge than in people with a normal 
body mass index. However, the OGTT represents an overall insulin response to the glucose load in 
chained from the OGTT which therefore combines many parameters derived from the minimal 
model analysis of the more complex FSIGTT.  
4.2 Experiment design and protocol 
The experiment described in this chapter was undertaken with the approval of the University of 
Queensland Animal Ethics Committee and complied with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. 
4.2.1 Animals and diet 
Eight mares， Thoroughbred (n=2) and Standardbred (n=6) aged 10 to 17 years from the previous 
Experiment 1 (n=4 from the HBCS group and n=4 from the LBCS group) were selected at days 14 
post-birth. Mares and their foals grazed a crop of oats (Avena sativa) to support the nutrition needs 
for lactation when fed pastures. Mares were served by the same Australian Stock Horse stallion on 
the third cycle after birth, with the day of ovulation (scan) being recorded. A positive pregnancy was 
detected in all mares around GD 45 (GD 0 = ovulation day). After weaning the foals at 4 to 6 
months of age, mares were returned to pasture that contained Rhodes grass (Chloris gayana) and 
lucerne (Medicago sativa) and the BCS were monitored until the commencement of the experiment. 
All pregnant mares were swapped from one pasture to another every fortnight. At mid-gestation 
(approximately GD 230), mares also were provided with 2.5 kg lucerne hay per day per horse.  
 
At the first step of this study, mares (at GD 230) were allocated from the previous HBCS group 
(PHBCS) and previous LBCS group (PLBCS). Additional supplement (lucerne hay or Pryde‟s 
Biomare cubes) was added when mares had BCS of 3 or less, whilst dietary restriction was used 
when a mare‟s BCS was greater than 6. All diets were balanced for minerals and energy based on 
NRC recommendations (2007) 
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4.2.2 Oral Glucose Tolerance Test  
Each mare was submitted to run OGTT at GD 325. Mares were fasted (with access to water) 
overnight for 15h (1700 to 0800 hours) prior to testing. At the beginning of the experiment, the skin 
over the external left jugular of the mare was shaved and cleaned using the Chlorohexidine solution 
and alcohol swab. Then a “basal” blood sample was taken from the vein using a 20G needle and 
10ml BD Vacutainers (BD-Plymouth. PL67BP.UK). Subsequently, mares were weighed and placed 
in individual stables. In the stables, Prilocaine
TM
 (2ml) was injected subcutaneously as a local 
anaesthetic near the external left jugular. Then, an angiocath (16 gauge, 5 ¼ inch) catheter, 
associated with extension sets (6 inch), was inserted into each side of the vein and secured with 
super-glue and elastoplast. The catheters and extension sets were flushed with heparinized saline 
(5,000 IU/L) to ensure they were patent. A swift swallow stomach tube (I.D. 8mm, Length 3.66m) 
was then placed in each mare. Following collection of a blood sample (time 0) a glucose load 
(Lotus pure glucose 97%) of 1 g/kg LW (in water) was given via the stomach tube. Blood samples 
were then collected at 15, 30, 45 and 60 min and thereafter at intervals of 30 min for a further 5 
hours after glucose load. Blood samples were tested using a glucometer (TrueTrack, Nipro 
Diagnostcs Inc, Osaka, Japan) immediately after collection then samples were centrifuged to obtain 
plasma for storage (-20℃). Animals were given limited access to feed and water at the end of the 
OGTT to avoid a sudden consumption of food. Due to the lower number of animals in each group, 
the areas under curve were log transformed to narrow the variability in t-test.  
4.2.3 Hormone assays  
Plasma insulin and leptin concentrations were determined as described in Chapter 3. The assay of 
adiponectin was performed using a commercial human adiponectin RIA kit (Millpore, Cat. 
#HADP-61HK) that had previously been verified for use in horses (Kearns et al., 2006). This kit 
contained 
125
I-labelled murine adiponectin with an activity of 67.7uCi/ug, a multispecies 
adiponectine rabbit antiserum and goat anti-rabbit IgG serum in the reagent. Samples were run by a 
three-day essay procedure and counted by gamma counter. The parallelism and standard in this 
assay were modified by serial dilution (1/250, 1/500, 1/1000, 1/2500, and 1/5000) of horse plasma 
and serial dilution of the control spiked with horse plasma as described by Kearns et al. (2006).  
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4.2.4 Statistical analyses 
A one-way ANOVA was performed to compare between the groups in terms of BCS and other 
parameters from OGTT. All analysis was conducted using Minitab
®
 16.1.0 software at a 95% 
confidence level and all values were expressed as means ± SEM.  
4.3 Results 
4.3.1 Physical measurement  
There was no significant difference (P<0.05) at GD 325 in BCS between groups in this follow-up 
experiment (Table 4.1), with the BCS being similar to the PLBCS group, but lower than PHBCS 
group, from the previous year.. However, the LW was significantly (P<0.05) higher in the PLBCS 
group compared to the PHBCS group (Table 4.2), although no differences between the two 
pregnancies were observed.  
 
Table 4.1: Body condition score in the current and previous pregnancies.  
Groups BCS of current pregnancy 
Expt 2 (GD 325)  
BCS of previous pregnancy 
Expt 1 (GD 320) 
PHBCS 4.3 ± 0.3
a
 6.8 ± 0.5
b
 
PLBCS 4.3 ± 0.3
a
 3.5 ± 0.4
a
 
Data in this table are means ± SEM. Different superscripts denote significant differences (P<0.05) between mare 
groups and experiments.  
 
 
Table 4 2: Live weight in current and previous pregnancy.  
Groups LW of current pregnancy 
Expt 2 (GD 325) 
LW of previous pregnancy 
Expt 1 (GD 320) 
PHBCS 487.5 ± 14.9
a
 502.2 ± 13.5
ab
 
PLBCS 548.0 ± 18.2
b
 539.1 ± 15.7
ab
 
Data in this table are means ± SEM. Different superscripts denote significant differences (P<0.05) between mare 
groups and experiments.  
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4.3.2 Oral Glucose Tolerance Tests 
There was no significant difference (P>0.05) between the mare groups for basal concentration of 
insulin, glucose, leptin or adiponectin on GD 325, the day of the OGTT (Table 4.3). In response to 
the glucose load, as expected, plasma glucose concentrations increased steadily in both mare groups 
over the initial 90 min (Figure 4.1). However, after 90 min plasma glucose concentrations declined 
in the PHBCS group, whilst they continued to increase in the PLBCS group, reaching a later peak at 
150 min post-glucose. By the end of the OGTT, glucose concentrations in both groups had returned 
to pre-treatment values. Plasma insulin concentrations in PHBCS rapidly increased in response to 
glucose load reaching a peak 4-fold higher than the basal concentrations at 15 min then decreased 
steadily afterwards. In contrast, insulin in PLBCS group increased slowly after the glucose load and 
reached a maximum average value only at 210 min. Overall for insulin during the OGTT there was 
no significant effect of mare group, but a significant (P<0.05) group by time interaction. However it 
should be noted that there was a quite variable insulin response between individual mares within 
groups during the OGTT as indicated by the large SE bars (Figure 4.2). This large variability 
combined with low numbers per group made detection of significant differences at individual time 
points difficult (only at times 240 and 270 min post-glucose load).   
 
Table 4.3: Basal plasma insulin, glucose, leptin and adiponectin concentrations on day 325 of 
gestation, the day of the OGTT 
 
Group Insulin 
(uIU/L) 
Glucose 
(mg/dl) 
Leptin (ng/ml) Adiponectin 
(ng/ml) 
PHBCS 1.8 ± 0.5 54.9 ± 9.4 1.8 ± 0.1 12.5 ± 1.6 
PLBCS 2.3 ± 1.3 72.0 ± 10.5 2.3 ± 0.5 9.9 ± 1.0 
Data in this table are means ± SEM. No significant differences were found between groups.  
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Figure 4.1: Plasma concentrations of glucose during the OGTT at day 325 of gestation. Data are 
means ± SEM. Significant effects of group at individual times were detected as show by ** 
(P<0.05).  
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Figure 4.2: Plasma concentrations of insulin during the OGTT at day 325 of gestation. Data are 
means ± SEM. Due to the significant effect of time versus treatment, significances are showed by 
** at the time point (P<005).  
 
To better interpret the responses during the OGTT the area under the curve for both glucose (AUCg) 
and insulin (AUCi) were calculated. Interestingly the total AUCg and AUCi were not significantly 
different between the mare groups (P>0.05, Table 4.4). However examining the acute insulin 
response (first 60 min) to the glucose load there was a significant difference between mare groups, 
with a reduced response in the PLBCS mare group. However, the AUCi within the first 60 min (the 
acute insulin response) showed a significant difference between the mare groups (P<0.05), with the 
areas for the PLBCS group being lower than for the PHBCS mares (Figure 4.3). No significant 
difference in the AUCi was found between mare groups from 60 min to 360 min. 
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Table 4.4: Total AUC for glucose (g) and insulin (i) during the OGTT on day 325 of gestation. 
Variables PHBCS PLBCS 
AUCg 17611 ± 6158 19946 ± 2077 
AUCi 2850 ± 1119 3050 ± 917 
Data in this table are r means±SEM. No significant differences were found between groups. Units in presented 
table are mIU.mins/L in insulin and mg.mins/dL in glucose.  
 
 
Figure 4.3: The AUC for insulin during the OGTT on day 325 of gestation. Data in this figure are 
means ± SEM. Column bearing ** means significant higher value analyzed by log transformed 
t-test (P<0.05).  
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4.4 Discussion  
Pregnancy in humans is usually associated with mild IR and hyperinsulinaemia and these 
characteristics are thought to be due to hormones secreted by the placenta, maternal adipose 
deposition and an increased food intake. GDM occurs in women when pancreatic β cell function is 
severely reduced, resulting in an impaired glucose tolerance during pregnancy, as well as a higher 
risk of developing GDM in the subsequent pregnancy (Jones, 2001). Obesity is considered as a 
factor that enhances the incidence of GDM (3 times) or type 2 diabetes (7 times) in women 
(Ehrenberg et al., 2002, Bellamy et al., 2009).  
 
In the experiment presented in Chapter 3, the hypothesis was that mares with a HBCS are at a 
higher risk of developing severe IR during pregnancy. However, the opposite was found with lean 
mares exhibiting severe IR and pancreatic β cell failure. It is possible that these LBCS mares might 
exhibit characteristic of GDM in women with abnormal insulin regulation extending to a 
subsequent pregnancy. To test this idea, mares were given an OGTT on GD 325 in their subsequent 
pregnancy. This day of gestation was chosen to match the timing of severe IR on GD 320 in the 
previous experiments in Chapter 3, but there was a delay of five days due to extreme weather 
conditions and adjustments due to the timing of ovulation and due day to ensure all mares were 
administrated OGTT at exactly the same GD. It is well known that IR becomes more severe at the 
end of pregnancy (Jones, 2001) and it was thought these extra five days would not alter the result 
significantly.  
 
In this experiment, the planned BCS was achieved. The BCS of mares was not significantly 
different between the groups at the time of the OGTT (GD 325). Lean mares in the PLBCS group 
maintained their relatively low BCS although the BCS increased from an average from 3 to more 
than 4. In contrast, mares in the PHBCS groups had a decrease in BCS over one year. All mares 
were monitored during early and mid-pregnancy to maintain individual health and pregnancy by 
adding supplements and feed when their BCS was extremely low (<BCS 3). The maintenance of 
relatively lean mares and the BCS reduction in previously fat mares may be explained by 
endogenous regulation. In nature, horses regulate appetite and growth to survive and maintain body 
conditions (Fuller et al., 2001). Basically, mares lose LW and BCS during lactation and pregnancy.  
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In this experiment, mares in both groups were grazed on oats and pasture during lactation and early 
and mid-pregnancy. Therefore, the PHBCS decreased body conditions during lactation and the 
subsequent pregnancy. In contrast, the PLBCS mares gained live weight in the subsequent 
pregnancy. This may have been due to an appropriate supplement being provided. All mares were 
placed on pasture and provide with a diet that matched the nutritional requirements during the last 
trimester of gestation. No significantly high or low energy concentrate, especially NSCs, were fed 
to these mares during pregnancy. Therefore, although it was planned that the mares in the PHBCS 
group would be fatter in the previous pregnancy, these mares actually decreased body condition 
naturally. The NSCs were restricted due to the observation of Hoffman et al. (2003a) and Treiber et 
al. (2005a) that these may enhance IR and hyperinsulineamia.  
 
In previous studies, several methods have been used for applying glucose to animals, including oral 
syringe dosing with corn syrup (Frank, 2012) and in-feed addition of glucose (Tinworth et al., 
2011b). Although some of these methods have been used to reduce the stress during glucose 
consumption, traditional nasogastric intubation was used in this experiment by using 1 g/kg glucose 
in a 20% water solution (Jeffcott et al., 1986). The benefit of this method is that the total amount of 
glucose was applied suddenly to the animal resulting in a rapid absorption of the glucose. Even 
thought, the nasogastric intubation did cause mild stress on mares although mare had no differences 
in glucose and insulin concentrations between the groups at the time of the first blood sampling.  
 
The response of oral glucose load is complex and includes glucose absorption from the 
gastrointestinal tract, entry of glucose into circulation, and glucose clearance, as well as secretion of 
various hormones. Although the OGTT is often used in some animals and humans to diagnose 
impaired glucose clearance, the glucose clearance is comprised of both insulin and non-insulin 
dependent glucose uptake. It at best indirectly indicates insulin sensitivity. The optimal method to 
diagnose insulin sensitivity is the glucose response to exogenous insulin injection, an insulin 
sensitivity test. However since insulin sensitivity is one component of glucose clearance, Stumvoll 
et al. (2000) indicated that the traditional OGTT can be used to predict both Si and β cell function 
using equations. Such methodology has not been proven in equine science. Further studies need to 
be performed in the future to refine the use of OGTT to predict Si in horses.  
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In the present study, the fasting insulin and glucose concentrations were not significantly different 
between the mare groups before the OGTT. In humans, basal glucose and insulin concentrations are 
often used as important indices for determining Si. However in our experiments (Chapter 3), despite 
a lower Si value from minimal model analysis was found in LBCS mares compared to HBCS mares, 
the basal concentrations of insulin and glucose were not significantly different. Similarly, no 
significant differences in basal concentrations of insulin and glucose were found in previous 
experiments with pregnant mares despite differences in Si (Dobbs, 2013). Therefore basal or fasting 
concentrations of insulin and glucose may not be reliable measurements for a prediction of insulin 
insensitivity in horses. In the present study, it showed that lower fasting insulin and glucose 
concentrations were measured compared to those reported previously for non-pregnant mares by 
Dobbs (2013). This is consistent with the evidence that in late pregnancy a state of insulin 
insensitivity occurs (Dahlgren, 2006). This experiment also presented lower basal insulin and 
glucose contents when comparing to the data reported by Dobbs (BCS 4.0 ± 0.0, insulin 9.6 ± 5.8 
mIU/L, glucose 93.9 ± 7.9 mg/dL). This difference may have been due to the dietary design where 
numbers of studies indicated the potential effects of pregnancy and adaptation on diets (Hoffman et 
al., 2003b, Saastamoinen et al., 1994). Another potential reason for the lower levels of insulin and 
glucose measured in the present study may be that relatively lean mares in the current experiment 
showed a delay in the presence of pre-partum surge of maternal glucocorticoids, which generally 
happened at 5 days prior to parturition and result in increased basal insulin and glucose levels.  
 
In the OGTT the glucose concentrations over the first 120 min post glucose load are indicative of 
the continuous absorption of glucose from the small intestine resulting in a peak value of double 
resting glucose values (Roberts and Hill, 1973). However, no significant difference was found 
between the groups in total AUCg. This indicates the total absorbed glucose load was similar 
between the mare groups. However despite the total AUCg being similar for both groups, in the 
PHBCS, the peak value of glucose was measured at 90 minutes and 60 minutes (ie 150 minutes) 
later to the glucose peak in the PLBCS group. For the accompanying insulin response, according to 
Haffner et al. (1996), the first 60 min post glucose load in an OGTT is considered as the „acute‟ 
phase of insulin secretion and β cell function. Insulin secretion in the first 60 minutes is expected to 
be quite high in response to the large increase in blood glucose. In PLBCS mares there was a 
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significantly lower insulin concentrations in this period, compared to PHBCS mares. The lack of 
appropriate insulin secretion in PLBCS mares in this period most likely resulted in a prolonged 
glucose peak (impaired glucose clearance) in these mares. In contrast a more robust insulin 
secretion in PHBCS mares promoted greater glucose uptake. Overall however there was no 
significant difference between the mare groups in total insulin concentrations, as determined by 
AUCi. This suggests that over time the glucose clearance required the same amount of insulin 
secretion for both groups of mares. What was different between the mare groups was the timing of 
insulin release and therefore as a consequence glucose clearance over time. The present results 
might also suggest that Si may be different between the groups due to glucose concentrations 
eventually returning to basal levels in both groups. However as mentioned above, a more direct test 
of insulin sensitivity would be required to confirm this idea. Irrespective of the glucose clearance, 
the relatively lack of acute insulin release 15 min after glucose load in PLBCS mares with a delayed 
peak insulin concentration at 210 min, clearly indicates pancreatic β cell dysfunction in these mares. 
Hyperglycaemia without hyperinsulinemia after the glucose load has been described as 
uncompensated IR in the horse by Treiber et al. (2005b). Similar impaired β cell function was found 
in non-pregnant Standardbred horses (Bamford et al., 2014).  
 
No significant difference of accumulative AUCi was found between 60 and 360 min between the 
groups. This may have been due to the PLBCS group having a compensatory insulin secretion after 
missing the acute phase, while insulin secretion in the PHBCS group rapidly increased followed by 
a steadily reduction in insulin secretion. This was shown as a cross over at 120 min post-glucose 
load in Fig 4.2. 
 
Overall, the present study demonstrates that mares with previous LBCS exhibiting severe IR and 
accompanying β cell failure during late pregnancy continued to display an impaired glucose 
tolerance and abnormal acute insulin responses to glucose (β cell dysfunction) in their subsequent 
pregnancy. In contrast, mares with previous HBCS exhibited a normal glucose clearance and an 
acute insulin response to glucose load in the OGTT.  
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5.1 Introduction 
In a previous study, IR was found to be associated with obesity in horses, and this condition may be 
of particular concern due to the putative link between laminitis and glucose metabolism (Hoffman 
et al., 2003b, Pass et al., 1998). It is possible that obesity in mares may affect foetal health and 
cause prolonged effects in later life and in foals as has been discussed by Dobbs (2013). Therefore, 
investigation of the physical status of mares during pregnancy may be of value in terms of limiting 
the wastage of unsalable foals.  
 
In the studies by George et al. (2011) and Dobbs (2013), it was found that a high energy dietary 
supplement exceeding general requirements during pregnancy will induce hyperinsulineamia and 
hyperglycaemia in mares. However, no significant effects on Si or BCS were found. Therefore, in 
this thesis, insulin and glucose responses following glucose challenges were examined in pregnant 
mares with disparate body conditions. The hypothesis explored was that obesity would exacerbate 
IR in pregnant mares. Although this was demonstrated, the remarkable outcome of the current 
studies was that mares with low BCS are more likely to develop GDM during the last trimester of 
gestation than mares with high BCS. As far as can be determined this is the first time this has been 
demonstrated in horses.  
 
Pregnant mares with LBCS of 3 to 4 developed severe insulin insensitivity and β cell failure during 
the last trimester at gestation (Chapter 3). Moreover, in the subsequent pregnancy, these mares 
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demonstrated β cell dysfunction and a degree of glucose intolerance (Chapter 4). Such features of 
glucose tolerance and pancreas insulin dysregulation are similar characteristics to those described in 
human GDM. However, obese rather than lean women are considered to be at a higher risk of 
developing GDM.   
5.2 General Considerations 
Although in the present studies evidence was obtained to indicate that lean mares are at risk of 
developing GDM during the last trimester of gestation, several limitations should be considered for 
further study. These experiments were conducted to investigate a number of complex hormone 
regulations with limited resources. Due to the high cost of horse husbandry and to the value of a 
horse itself, the number of mares in this research was restricted. The statistical persuasion therefore 
was reduced to indicate a general syndrome. Moreover, two Thoroughbred and eleven Standardbred 
horses were used in experiment one. It is unknown whether this breed difference affected the results 
obtained. However, all mares in the second experiment were Standardbred horses and they 
exhibited a respectively defective insulin secretion. Therefore, although concern remained, further 
studies examining breed difference in Si and GDM would be helpful.   
 
It is known that insulin secretion may increase under stress (Wilcox, 2005). Animals underwent 
limited surgery such as catheter insertion and intubation during sampling. It is possible that such 
surgery may have induced stress in the animals, reducing the accuracy of measurement of actual 
insulin concentration. It is also impossible to avoid other environmental factors such as human 
activity, rain or sudden noise which may induce stress on the animal prior to, or during sampling.  
 
The current study used the system developed Henneke et al. (1983) to evaluate BCS. This is a 
subjective system based on vision and palpation of the mare‟s body. This method has been 
questioned as it appears to be less accurate with fatter mares (Dugdale et al., 2012). What is 
required is a technique that determines body composition. To obtain a better appreciation of the 
relationship between body composition and traditional BCS evaluation circulating leptin and 
adiponectine were measured. It is known that in horses there is a positive correlation between leptin 
and fat deposition and a negative correlation between adiponectine and fat deposit (Kearns et al., 
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2006b). It was apparent from the results (Chapters 3 and 4) that leptin reflects body condition in the 
mare. However, the higher deviation of leptin concentrations found in HBCS mares compared to 
LBCS mares (Chapter 3) is in agreement with the concern of Dugdale et al. (2012) that current BCS 
evaluation systems is less accurate in mares with HBCS. The results were inconclusive for 
adiponectine (Chapter 4) due to low mare numbers and the similar BCS scores between groups.  
5.3 Insulin resistance and dysfunction in pregnant mares  
The GDM is defined as any degree of impaired glucose tolerance which is first observed during 
pregnancy. In normal pregnancy, physiological regulations occur leading to decreased Si, impaired 
glucose clearance, and in response to those conditions increased or compensated insulin secretion 
from pancreatic β cells. These physiological changes are required to provide an ample supply of 
energy and other nutrients, particularly glucose for the developing placenta and foetus. Pregnant 
women are considered to be susceptible to developing diabetes after the first trimester of gestation 
when IR and hyperinsulinaemia become more prominent features. This then been demonstrated by 
measuring responses to intravenous glucose(Buchanan et al., 1990). A severe IR during gestation 
may chronically cause insufficient β cell function which increases the risk for future glucose 
intolerance, as manifested by maternal diabetes or by recurrent GDM in subsequent pregnancies 
(O'Sullivan, 1991). The significantly lower Si and AIRg in the study reported in Chapter 3 are 
consistent with the reduced Si and β cell failure in mares with low BCS (3 to 4) during the last 
trimester of gestation. These are primary characteristics of GDM in women (Kjos and Buchanan, 
1999).  
 
It has been detected to shown that mean insulin sensitivities may be similar in normal women and 
those with GDM in the late phases of pregnancy, which is consistent with that insulin action being 
functional at that period (Buchanan et al., 1990). In contrast, in women with GDM significantly 
reduced insulin sensitivities have been measured during the first- and second-phase of pregnancy. 
This may be due to reciprocal changes in Si and β cell function raising the possibility that GDM is 
featured by a β cell failure rather than a more severe IR (Buchanan et al., 1990). This defect of β 
cell function may continue later in life to cause a high risk of future glucose intolerance and 
maternal diabetes as has been found in women (Getahun et al., 2010). Data reported in Chapter 4 
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are in conformity with this: mares with previous LBCS that exhibited β cell failure during late 
pregnancy, once again displayed impaired glucose tolerance and inappropriate insulin secretion in a 
subsequent pregnancy. Although GDM has not been reported in mares previously, present evidence 
provides compelling results that GDM can also occur in mares.  
 
The GDM is found to affect 4 to 12% of pregnancies but resolves after pregnancy in approximately 
90% of women (Kjos et al., 1990). However, this prevalence may vary according to racial groups. 
Although in the present studies all mares with LBCS exhibited GDM in both experiments further 
studies should be conducted to confirm this.  
5.4 Body condition  
Researches studying humans use body mass index (kg/m
2
) to estimate whether pregnant women are 
at risk of GDM due to obesity. It has been found that overweight or obese women in the first 
pregnancy who reduce their BMI between pregnancies appear to have a lower incidence of GDM in 
subsequent pregnancies (Ehrlich et al., 2011). In the present studies, a significant difference of BCS 
was achieved in experiment one (Chapter 3). According to Henneke‟s system (1983), mares in this 
study with LBCS were defined as thin or moderately thin and those with HBCS as moderately 
fleshy or fleshy (Appendix 1). Therefore, the low BCS mares in which insulin insensitivity and the 
failure of β cell function were measured (Chapter 3) were considered as lean or thin mares, while 
HBCS mares were considered as overweight but not obese. In the subsequent pregnancy (Chapter 
4), LBCS mares had slightly increased BCS from an average of 3.5 to 4.3 and displayed β cell 
failure of again. Although HBCS mares reduced their BCS to thin or moderately thin in the 
subsequent pregnancy, they only showed mild IR rather than severe insulin insensitivity and β cell 
dysfunction which is a common feature of pregnancy. Researchers studying humans have found that 
women who are either obese or in lean body condition are at risk of developing GDM during 
gestation (Kjos and Buchanan, 1999, Kautzky-Willer et al., 1997). One mare with extreme obesity 
(BCS>9) was found to have a Si and β cell failure, similar to the LBCS group mares (Chapter 3). 
This observation leads to the suggestion that pregnant mares should be maintained at BCS 6 to 7 to 
reduce the risk of developing GDM.  
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The current evaluation system is based on visual and palpationed evaluation around the mares‟ body 
(Henneke et al. 1983). This method has been questioned by others who have suggested that the 
current BCS system is less accurate in fatter mares (Dugdale et al., 2012).  Therefore, assays of 
leptin and adiponectine were used in this study to minimize the error from traditional BCS 
evaluations. It is known that a positive correlation occurs between leptin and fat deposits while 
there is a negative relationship between adiponectine and fat deposition (Kearns et al., 2006). The 
present results (Chapter 3 and 4) are consistent with this concept with significantly higher leptin 
measured in HBCS mares compared to LBCS mares. However, its should be noted that there was 
considerate variation in plasma leptin in HBCS mares compared to LBCS mares (see Table 3.3), 
which is consistent with the concern of  Dugdale et al. (2012) that current BCS evaluation is less 
accurate in high BCS mares. Due to limited resources, adiponectine was only measured in 
experiment two. No significant difference, meaning that the BCS were similar between groups.  
5.5 Implications and further study 
In this thesis, GDM in pregnant mares has been described for the first time. The results are 
consistent with pregnant mares with lean BCS during pregnancy being predisposed to GDM. 
Demonstrating the importance of a mare‟s body condition (composition) during pregnancy, body 
condition reflects both genetic and environmental factors and of which, diet and diet intake are the 
most important. Finally, these results pose as many questions as they answered. Further research 
should be conducted to determine:  
 What features of a diet perturb insulin and glucose regulation in pregnant mares? 
 Does GDM occur more generally in mares or is it breed specific?  
 Does maternal insulin deregulation have long term effects on foal health?  
5.6 Conclusion 
Compelling evidence has been obtained that a mare‟s physical status (ie body condition) can alter 
her metabolism during pregnancy. Pregnant mares with low body condition are at risk of developing 
GDM during late pregnancy. Therefore it is important to maintain appropriate nutrient intake and 
body condition when managing mares during late pregnancy. 
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Appendix 1. Description of body condition scores in horses (Henneke et al., 1983). 
Score Description 
1 Poor Animal extremely emaciated. Spinous processes, ribs, tailhead, tuber coxae 
and ischii projecting prominently. Bone structure of withers, shoulders and 
neck easily noticeable. No fatty tissue can be felt 
2 Very Thin Animal emaciated. Slight fat covering over base of spinous processes, 
transverse processes of lumbar vertebrae feel rounded. Spinous 
processes, ribs, tailhead, tuber coxae and ischii prominent. Withers, 
shoulders and neck structures faintly discernable  
3 Thin Fat build up about halfway on spinous processes, transverse processes 
cannot be felt. Slight fat cover over ribs. Spinous processes and ribs 
easily discernable. Tailhead prominent, but individual vertebrae cannot be 
visually identified. Tuber coxae appear rounded, but easily discernable. 
Tuber ischii not distinguishable. Withers, shoulders and neck accentuated 
4 Moderately 
thin 
Negative crease along back. Faint outline of ribs discernable. Tailhead 
prominence depends on conformation, fat can be felt around it. Tuber coxae 
not discernable. Withers, shoulders and neck not obviously thin 
5 Moderate Back level. Ribs cannot be visually distinguished but can be easily felt. 
Fat around tailhead beginning to feel spongy. Withers appear rounded 
over spinous processes. Shoulders and neck blend smoothly into body 
6 Moderately 
fleshy 
May have slight crease down back. Fat over ribs feels spongy. Fat around 
tailhead feels soft. Fat beginning to be deposited along the side of the 
withers, behind the shoulders and along the sides of the neck 
7 Fleshy May have crease down back. Individual ribs can be felt, but noticeable 
filling between ribs with fat. Fat around tailhead is soft. Fat deposited 
along withers, behind shoulders and along the neck 
8 Fat Crease down back. Difficult to feel ribs. Fat around tailhead very soft. Area 
along withers filled with fat. Area behind shoulder filled with fat. Noticeable 
thickening of neck. Fat deposited along inner thighs 
9 Extremely 
fat 
Obvious crease down back. Patchy fat appearing over ribs. Bulging fat 
around tailhead, along withers, behind shoulders and along neck. Fat 
along inner thighs may rub together. Flank filled with fai 
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Appendix 2 Nutrient and mineral content of feeds used in Experiment 1 (Chapter 3) (WL Bryden. 
pers.com).  
Major Nutrients and minerals Units Pryde‟s Bio Mare Fake Barley Pastures Hay 
Digestible Energy  MJ/kg DM 14.2 14.0 8.2 6.6 
Crude Protein g/kg DM 158.0 130.0 160.0 141.0 
Calcium g/kg DM 11.5 1.2 3.9 3.9 
Phosphorous g/kg DM 8.7 3.4 4.4 5.2 
Magnesium g/kg DM 1.6 1.4 1.5 2.4 
Sodium g/kg DM 6.0 2.2 0.8 8.79 
Potassium g/kg DM 6.5 7.3 21.2 28.6 
Zinc mg/kg DM 153.0 22.0 55.0 59.0 
Manganese mg/kg DM 116.0 19.0 1.5 49.0 
Copper mg/kg DM 54.0 10.0 20.0 19.0 
Iron mg/kg DM 168.0 97.0 443.0 292.0 
Cobalt mg/kg DM 0.5 0.2 N/A N/A 
Vitamin A IU/kg DM 9000.0 0.0 N/A N/A 
Vitamin D IU/kg DM 1050.0 0.0 N/A N/A 
Vitamin E IU/kg DM 140.0 31.0 N/A N/A 
Crude Fat g/kg DM 37.0 30.0 32.0 15.0 
Crude Fibre g/kg DM 38.0 55.0 1.0 0.8 
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Appendix 3  Record Sheet for FSIGTT 
Mare # : Date: Time: 
Mare weight: Glucose: Insulin: 
Time Actual time Glucose reading 
0 min (Basal)   
Administer glucose   
1 min   
2 min   
3 min   
4 min   
5 min   
6 min   
8 min   
10 min   
12 min   
14 min   
16 min   
19 min   
20 min (Insulin injection)  N/A 
22 min   
23 min   
24 min   
25 min   
27 min   
30 min   
35 min   
40 min   
50 min   
60 min (1 hour)   
70 min   
80 min   
90 min (1 and half hour)   
100 min   
120 min (2 hours)   
150 min (2 and half hours)    
180 min (3 hours)   
240 min (4 hours)   
 
